SkyWater Technology

SkyWater Technology Inc is a pure-play technology foundry that offers advanced semiconductor development and manufacturing services from its fabrication facility, in Minnesota and advanced packaging services from the Florida facility. It specializes in advanced Innovation Engineering Services and volume manufacturing of a wide variety of differentiated integrated circuits.

Skytop Lodge

SKYTOP LODGE CORP 7 PFD by Skytop Lodge Corp.

SkyCity Enter Gr

What Happened:&nbsp;A popular French DJ David Guetta is selling his Miami apartment for cryptocurrency.
The three-bedroom 2528 square feet is represented by the Freud Group, which is known for working with high-profile clients.
According to the Freud site, Guetta&rsquo;s pud is priced at $14 million, and the &ldquo;seller will be accepting Crypto Currencies for this transaction! (Bitcoin and Ethereum) (sic),&rdquo; which would make it 398 BTC or 5838 ETH at press time.
What Else: This is not Guetta&rsquo;s first interaction with the crypto industry.
&nbsp;In September, the DJ partnered with a decentralized vertical reality platform Sensorium Galaxy.
The platform is planning to broadcast shows created by Guetta, who is no stranger to online-only performances. He performed several one-person shows during the COVID-19 pandemic last year.
Image: Courtesy of Freud Group

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Fintech news covering the emerging Financial Technology services sector

Fintech

News

Global

Markets

General

Real Estate

$BTC

$ETH

Famous DJ David Guetta Is Selling His Apartment For 390 BTC

The Group B Euro 2020 matchup between Denmark and Finland saw one of the worst and most talked about injuries in professional sports.
Viewers of the game on ESPN, a unit of Walt Disney Co.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dis#NYSE">DIS</a>), saw Christian Eriksen collapse and receive medical attention on the field.
The game was suspended for some time while fans and teammates awaited news on Eriksen&rsquo;s status and condition. A phone call from Eriksen in the hospital to teammates led to Denmark making the decision to continue the game.
Denmark, which was heavily favored to win the game with odds of -305 on DraftKings Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dkng#NASDAQ">DKNG</a>), lost to Finland 0-1 in a game that soccer experts questioned why it needed to be resumed Saturday.
Related Link: <a href="https://www.benzinga.com/general/sports/21/06/21483992/euro-2020-group-b-betting-preview-and-picks">Euro 2020 Group B Betting Preview And Picks&nbsp;</a>
Updated Betting Odds: The injury to Eriksen and the loss to Finland has made a large impact on betting odds going forward for Denmark and the rest of Group B.
Entering the Euro 2020 Tournament, Denmark <a href="https://www.benzinga.com/general/sports/21/06/21483992/euro-2020-group-b-betting-preview-and-picks">had odds </a>of +260 to win Group B, with Belgium favored at -139 and Russia +525 and Finland at +3000 being the other underdogs.
On Saturday, odds on DraftKings changed to -455 for Belgium, +800 Denmark, +1050 Finland and +2500 Russia to win Group B.
Belgium&rsquo;s odds improved slightly to +650 from +750 to win the Euro 2020. The odds likely improved as the team is more in control of Group B, which would lead to a more favorable first-round matchup with a group win.
Denmark, which was a <a href="https://www.benzinga.com/news/21/06/21521144/euro-2020-how-to-watch-betting-preview-picks-to-win-golden-boot">popular sleeper pick</a> to win the Euro 2020 at odds of +2500, now has odds of +4000 to win the tournament.
Denmark will enter its matchup on Thursday, June 17, vs. Belgium as a heavy underdog at +320 to win and +245 to tie. The team has odds of +110 to beat Russia on June 21.

Sports

DKNG

How The Christian Eriksen Injury Affects Euro 2020 Betting Odds

On <a href="https://twitter.com/OptionsAction/status/1403468873211564033">CNBC&#39;s &quot;Options Action,&quot;</a> Tony Zhang said there is a potential downside in Okta Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/okta#NASDAQ">OKTA</a>).
The stock is trading in a very wide range between $210 and $290, it has underperformed its sector and recently it recorded some lower highs. It also had a strong last week, which Zhang sees as an opportunity to look for some short exposure. He expects the stock to test its support at $210.
To make a bearish bet, Zhang wants to buy the August $220/$190 put spread for a total cost of $8.60. The trade breaks even at $211.40 or 6.62% below the closing price on Friday. If the stock drops at least 16%, to $190 or lower, the trade is going to reach its maximal profit of $21.40.

Short Ideas

Options

Media

Trading Ideas

OKTA

Tony Zhang's Okta Options Trade

In the gambling universe, a sharp refers to a person or group that has a good track record betting on games.
Sometimes, sharps will sell their picks to other bettors to tail.
Unlike recreational gamblers, sharps take betting very seriously and often bet large sums of money on single bets.
Now, recreational sports bettors in certain states can go to sites such as&nbsp;Draftkings Inc&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dkng#NASDAQ">DKNG</a>) or Penn National Gaming&#39;s (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/penn#NASDAQ">PENN</a>) Barstool Sportsbook, making sports gambling even more popular.&nbsp;
Tricks From Sharp &mdash;&nbsp;Making Sense of the Books: Oddsmakers have a great understanding of how the public likes to bet. For instance, because most sports fans like watching an exciting, high-scoring game, bettors almost always favor the over. This allows oddsmakers to set the over/under higher than it should be because they know the public can&rsquo;t help but take the over and root for a lot of points, goals or runs.
Watch Out For Moving Lines: Odds for games will often change from when the lines open&nbsp;to game time.
For example, the Los Angeles Lakers could be listed as 10-point favorites when betting opens on the game. But, if it comes out the day before the game that Lebron James is hurt and going to miss the game, the line could be affected.
It&rsquo;s important for bettors to watch out for moving lines&nbsp;and understand why the lines are moving.
Reverse Line Movement: <a href="https://www.thesportsgeek.com/blog/tips-to-help-you-bet-like-a-sharp/">Many sites allow you</a> to see what the &quot;public bet&quot;&nbsp;is on. This means that if 80% of people are betting on the Lakers against the Phoenix Suns and the Lakers are 10-point favorites, you will be able to see it.
It would be expected&nbsp;if 80% of the public are taking one side, the line would move in that direction and&nbsp;the Lakers would become 11-point favorites.
But this is not always what happens, sometimes the line will move in the opposite direction.
This is because even though 80% of public tickets are coming in on the Lakers, large bets could be placed on the Suns. The percentage of public bet does not equal the total amount of money being bet on one side.
Any time there is reverse line movement, it&#39;s because large bets, or whales, are taking the other side.
(Photo: <a href="https://unsplash.com/@introspectivedsgn">Erick McLean</a> via <a href="https://unsplash.com/">Unsplash</a>)

Education

PENN

Professional Gamblers And 'Sharps' Use These Tricks: Why Don't More Sports Bettors?

<ul>
<li>Benzinga has examined the prospects for many investor <a href="https://www.benzinga.com/trading-ideas">favorite stocks</a> over the past week. </li>
<li>The past week&#39;s bullish calls included the e-commerce leader, a top biotech and the airlines.</li>
<li>The iPhone maker, the top cryptocurrency and a COVID-19 vaccine maker were among the bearish calls seen.</li>
</ul>
The big three U.S. indexes offered mixed signals last week, with the Nasdaq ending almost 2% higher, the S&amp;P 500 up fractionally and the Dow Jones industrials lagging with almost a 1% retreat.
The S&amp;P 500 did manage to <a href="https://www.benzinga.com/news/earnings/21/06/21529911/chewy-earnings-beat-expectations-and-travel-industry-now-in-focus-ahead-of-summer">eke out a new record</a> high last week, but overall, Wall Street seemed to be in wait and see mode, with speculation that the reopening cycle may have already peaked, former drivers <a href="https://www.benzinga.com/news/earnings/21/06/21493474/gamestop-earnings-expected-later-today-with-chewy-seen-reporting-tomorrow">tech and financials still sputtering</a> and ahead of the coming week&#39;s FOMC meeting. The <a href="https://www.benzinga.com/markets/cryptocurrency/21/06/21512345/stock-market-volume-has-been-subdued-outside-of-meme-stocks-like-clov-and-wwe">Consumer Price Index</a> came in hotter than expected, though the muted market reaction suggests inflation fears may have already been priced in.
Bucking the low volume trend last week were the meme stocks, which offered retail investors another wild ride. In addition, a notable FDA drug approval gave <a href="https://www.benzinga.com/markets/binary-options/21/06/21474477/pharma-biotech-stocks-start-week-with-a-bang-after-biogens-alzheimers-approval">biotech stocks a bit of a boost</a>. Still, some investment firms are anticipating a <a href="https://www.benzinga.com/news/earnings/21/06/21452867/on-the-doorstep-s-p-500-begins-week-close-to-record-highs-with-inflation-data-up-next">muted second half of the year</a> for the markets.
The week also saw the <a href="https://www.benzinga.com/news/21/06/21510932/keystone-xl-pipeline-shut-down-what-investors-should-know-about-owner-tc-energy" target="_blank">Keystone Pipeline shut down</a>, a <a href="https://www.benzinga.com/news/21/06/21475029/what-to-know-about-the-glitch-that-crashed-the-internet-today">major internet outage</a>, the <a href="https://www.benzinga.com/topic/wwdc" target="_blank">Worldwide Developers Conference</a> and an agreement on a <a href="https://www.benzinga.com/news/21/06/21446570/g7-agrees-to-minimum-15-corporate-tax-reuters">global corporate tax</a>.
Through it all, Benzinga continued to examine the prospects for many of the stocks most popular with investors. Here are a few of this past week&#39;s most bullish and bearish posts that are worth another look.
<h3>The Bulls</h3>
Although Amazon.com, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amzn#NASDAQ">AMZN</a>) has lagged other FAANG names over the last year, its growth momentum will continue. So says the investment strategist featured in Adam Eckert&#39;s &quot;<a href="https://www.benzinga.com/trading-ideas/long-ideas/21/06/21498912/stephanie-link-sees-continued-growth-momentum-for-amazon-stock">Stephanie Link Sees Continued Growth Momentum For Amazon Stock</a>.&quot;
Be sure to check out <a href="https://www.benzinga.com/news/21/06/21480549/amazon-sidewalk-what-investors-device-owners-should-know">Amazon Sidewalk: What Investors, Device Owners Should Know</a> as well.
In &quot;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/21/06/21475260/5-biogen-analysts-on-fda-approval-of-alzheimers-drug-aduhelm-broad-label-pricing">5 Biogen Analysts On FDA Approval Of Alzheimer&#39;s Drug Aduhelm, Broad Label, Pricing</a>,&quot; Shanthi Rexaline reveals why some see a strong drug launch ahead for Biogen Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/biib#NASDAQ">BIIB</a>).
Also read <a href="https://www.benzinga.com/general/biotech/21/06/21497288/3-major-trends-in-biotech-that-are-revolutionizing-medical-research">3 Major Trends in Biotech that are Revolutionizing Medical Research</a>.
&quot;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/21/06/21514443/mkm-partners-initiates-coverage-on-airline-sector-names-delta-top-pick">MKM Partners Initiates Coverage On Airline Sector, Names Delta Top Pick</a>&quot; by Wayne Duggan examines expectations for Delta Air Lines, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dal#NYSE">DAL</a>) and its peers as Americans take to the sky again.
Phil Hall&#39;s &quot;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/21/06/21476936/ubs-analyst-upgrades-target-what-you-need-to-know">UBS Analyst Upgrades Target: What You Need To Know</a>&quot; discusses why Target Corporation&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tgt#NYSE">TGT</a>) valuation is modest compared to its peers and there is more to come from the retailer this year.
For more on Target, see <a href="https://www.benzinga.com/news/21/06/21493637/target-hikes-quarterly-dividend-by-32">Target Hikes Quarterly Dividend by 32%</a>.
In Priya Nigam&#39;s &quot;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/21/06/21513160/jpmorgan-upgrades-ups-after-recent-sell-off">JPMorgan Upgrades UPS After Recent Sell-Off</a>,&quot; discover why the United Parcel Service, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ups#NYSE">UPS</a>) investor day impressed one top analyst, who now sees an &quot;attractive entry point&quot; for the shares.
<h3>The Bears</h3>
&quot;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/21/06/21485632/apple-will-find-it-hard-to-recover-from-fallout-over-app-store-policies-says-bill-g">Apple Will Find It Hard To Recover From Fallout Over App Store Policies, Says Bill Gurley</a>&quot; by Madhukumar Warrier explores how Apple Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aapl#NASDAQ">AAPL</a>) could have avoided the mess in which it finds itself.
On the other hand, check out <a href="https://www.benzinga.com/markets/options/21/06/21515456/apple-options-traders-pile-in-despite-market-uncertainty">Apple Options Traders Pile In Despite Market Uncertainty</a>.
In Adrian Zmudzinski&#39;s &quot;<a href="https://www.benzinga.com/markets/cryptocurrency/21/06/21515065/bitcoin-might-be-entering-a-bearish-market-jpmorgan-analysts-suggest">Bitcoin Might Be Entering A Bearish Market, JPMorgan Analysts Suggest</a>,&quot; find out what signal one top analyst sees as pointing to a bear market for Bitcoin (CRYPTO: BTC) despite its recent price movements.
See <a href="https://www.benzinga.com/markets/cryptocurrency/21/06/21475197/is-the-game-over-for-bitcoin-why-crypto-influencers-think-it-could-get-worse">Is The Game Over For Bitcoin? Why Crypto Influencers Think &#39;It Could Get Worse&#39;</a> for more low expectations for this top cryptocurrency.
Wayne Duggan&#39;s &quot;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/21/06/21475069/2-reasons-why-tesla-has-become-an-ev-stock-laggard">2 Reasons Why Tesla Has Become An EV Stock Laggard</a>&quot; shows that there has been a clear shift in investor sentiment toward Tesla, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>)relative to other electric vehicle stocks.
<a href="https://www.benzinga.com/trading-ideas/long-ideas/21/06/21528545/teslas-stock-steers-into-triangle-and-looks-to-choose-direction">Tesla&#39;s Stock Steers Into Triangle And Looks To Choose Direction</a> offers a look at the chart at the end of a week full of good news and bad for the EV leader.
The Moderna, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrna#NASDAQ">MRNA</a>) stock run could be over as COVID-19 fades from the headlines, according to &quot;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/21/06/21512375/why-bofa-is-bearish-on-moderna-despite-covid-19-vaccine-success">Why BofA Is Bearish On Moderna Despite COVID-19 Vaccine Success</a>&quot; by Shanthi Rexaline.
In &quot;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/21/06/21512630/bofa-downgrades-clover-health-after-100-stock-surge">BofA Downgrades Clover Health After 100% Stock Surge</a>,&quot; Priya Nigam looks at how recent price moves have overshadowed the prospects for meme stock Clover Health Investments Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clov#NASDAQ">CLOV</a>).
Keep up with all the latest breaking news and trading ideas by following <a href="https://twitter.com/Benzinga">Benzinga</a> on Twitter.

Long Ideas

AAPL

AMZN

BIIB

CLOV

MRNA

TSLA

Benzinga's Bulls And Bears Of The Week: Apple, Amazon, Biogen, Bitcoin, Tesla And More

Thailand has banned all meme tokens, fan tokens, exchange tokens and non-fungible tokens (NFTs), the country&rsquo;s Securities and Exchange Commission said in a <a href="https://www.sec.or.th/TH/Pages/News_Detail.aspx?SECID=8991" style="text-decoration-line:none">statement</a> Friday.
What Happened: The Thai SEC didn&rsquo;t specifically mention the high-profile cryptocurrency Dogecoin (DOGE), which is expected to fall under the category of meme tokens, CoinDesk, which first <a href="https://www.coindesk.com/no-doge-allowed-thai-sec-bans-meme-fan-and-exchange-tokens-as-well-as-nfts" style="text-decoration-line:none">reported</a> the news, noted.
See Also: <a href="https://www.benzinga.com/money/how-to-buy-dogecoin-doge/" style="text-decoration-line:none">How to Buy Dogecoin (DOGE)</a>
Dogecoin, created as a joke in late 2013, is up 5456% in 2021, as of press time &mdash; the highest among the top 10 cryptocurrencies by market capitalization. The meme coin has found a major backer in Tesla Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) CEO Elon Musk.
The Thai regulator described meme cryptocurrencies as ones whose price is primarily driven by social indicators and have no clear objective or substance on their own.
Fan tokens representing ownership of voting rights or access to club-specific rewards and services are also now banned in Thailand, CoinDesk noted. An exception would be fan tokens used for goods and services like VIP experiences.
NFTs, another hot trend of 2021, also stand banned, alongside cryptocurrencies issued by exchange desks like Binance, Uniswap, and FTX for on-platform benefits.
Price Action: Dogecoin traded 1.7% lower at $0.3149 at press time on Sunday.
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/21/06/21504329/exclusive-dogecoin-co-creator-on-development-efforts-says-no-knock-on-elon-others-but-acti" style="text-decoration-line:none">Dogecoin Co-Creator On Development Efforts Says &#39;No Knock On Elon,&#39; Others But Actions Speak Louder Than Words</a>

$DOGE

Dogecoin Not Cute Enough For Thailand, Country Bans All Meme Coins, NFTs

On <a href="https://www.cnbc.com/video/2021/06/11/adobe-earnings-coming-up-and-heres-what-the-chartmaster-sees.html">CNBC&#39;s &quot;Options Action,&quot;</a> Carter Worth said he thinks Adobe Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adbe#NASDAQ">ADBE</a>) is solid and strong. The stock has returned where it was almost a year ago and it has just started to show relative outperformance to the S&amp;P 500. Worth noticed several technical patterns that suggest the stock has bottomed and he expects it to break out on the upside.
Mike Khouw wants to use options to make a bullish bet. With earnings coming up on June 17, short-term implied volatilities are elevated relative to the long-term implied volatilities so he wants to take advantage of that dynamic by buying the September $540 calls for $28.35 and selling the June $555 calls for $4.60. The trade would cost him $23.75, which is the maximum amount he can lose. If the stock trades sharply higher, above $555 the trade is going to underperform as the spread is only $15 wide.

ADBE

Carter Worth And Mike Khouw's Adobe Trade

On <a href="https://www.cnbc.com/video/2021/06/11/cramer-lightning-round-buy-spotify-at-these-levels.html">CNBC&#39;s &quot;Mad Money Lightning Round,&quot;</a> Jim Cramer said Restoration Hardware Holdings (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rh#NYSE">RH</a>) is just getting started and it goes higher.
Moody&#39;s Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mco#NYSE">MCO</a>) is a buy, said Cramer. He likes S&amp;P Global Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spgi#NYSE">SPGI</a>) better.
Cramer would hold NVIDIA Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvda#NASDAQ">NVDA</a>) and he would buy more if it drops below $700.
Never bet against Eric Grubman, said Cramer. He is a buyer of his SPAC, Sports Entertainment Acquisition Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/seah#NYSE">SEAH</a>).
ChargePoint Holdings Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chpt#NYSE">CHPT</a>) is very good, but it has three other competitors Cramer analyzed. With that much competition, he feels it&#39;s difficult to own the stock.
At these levels, you want to buy Spotify Technology SA (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spot#NYSE">SPOT</a>), said Cramer.

Small Cap

CHPT

NVDA

SEAH

SPGI

SPOT

Cramer Gives His Opinion On Nvidia, Spotify And More

The Euro 2020 is set to begin June 11 with the Group Stage and run through July 11. The games will be aired on ESPN and EPSN+, both units of&nbsp;Walt Disney Co&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dis#NYSE">DIS</a>).
Ahead of the quadrennial soccer tournament featuring the top teams in Europe, Benzinga is providing group betting previews. Group D Betting Odds from Draftkings Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dkng#NASDAQ">DKNG</a>) are:
<ul>
<li>England to win group -250, to finish top two in group -1250</li>
<li>Croatia to win group +390, to finish top two in group -150</li>
<li>The Czech Republic to win group +1150, to finish top two in group +200</li>
<li>Scotland to win group +1900, to finish top two in group +310</li>
</ul>
There are many betting options for soccer games including betting on the winner, a tie, a team to win or tie, over/under, correct score, both teams to score and the winning margin.
For this betting preview, we will be looking at who is likely to win Group D and finish second as the top two teams will advance past the group stage.
England (FIFA rank: 4) is a significant favorite in the group stage. It would be a pretty big upset if England didn&rsquo;t win the group. The team went 7-0-1 in qualifying with 37 goals scored and 6 goals allowed.
The team did lose to the Czech Republic 2-1 which could make its matchup a revenge game. Harry Kane led all players in the qualifying rounds of the Euro with 12 goals. Raheem Sterling added 8 goals.
Croatia (FIFA rank: 14) is the favorite to finish second. The team went 5-2-1 in qualifying in a group including&nbsp;Wales and Slovakia. In 2021, Croatia has faced off against some weaker competition such as&nbsp;Cyprus, Slovenia, Malta and Armenia. The results have been mixed.
The Czech Republic (FIFA rank: 40) went 5-0-3 in qualifying and is being considered a sleeper pick to finish second in the group. The team will need to figure out its goal-scoring with only 13 goals scored in 8 qualifying matches.
Scotland (FIFA rank: 44) went 5-0-5 in qualifying and faces a tough group to get out of. The team had a goal differential of -3 and allowed 19 goals.
Group D Picks: The safe bets seem to be England winning the group and Scotland finishing&nbsp;fourth. The real matchup is between Croatia and the Czech Republic to finish second.
Given the odds paying better for the Czech Republic, the value could be there for bettors with that country having a good shot of finishing second in Group D.
(Image by&nbsp;<a href="https://pixabay.com/users/jarmoluk-143740/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=488700">Michal Jarmoluk</a>&nbsp;from&nbsp;<a href="https://pixabay.com/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=488700">Pixabay</a>)

Euro 2020 Group D Betting Preview And Picks

The Taproot soft fork for Bitcoin (BTC) has locked in, as per Taproot.Watch, and is now set to be activated in November on block number 709,632.
What Happened:&nbsp;The threshold of more than 90% of all blocks signaling support for Taproot was crossed Sunday morning. This meant that at least 1,815 of 2,016 blocks within a 2-week difficulty period signaled support for the upgrade.
Taproot is expected to improve the privacy and fungibility of Bitcoin, alongside lowering transaction fees and incorporate efficiency improvements.
See Also: <a href="https://www.benzinga.com/money/how-to-buy-bitcoin/">How To Buy Bitcoin</a>
The soft fork will be the most significant upgrade to Bitcoin&rsquo;s blockchain since SegWit, a soft fork activated in 2017.
As part of Taproot, the existing elliptic curve digital signature algorithm of Bitcoin will be replaced with Schnorr signatures, considered to be more secure, privacy-oriented, and better-suited for multisignature transactions by proponents.
The 5-month period between the locking and the implementation of the actual upgrade allows miners the time to upgrade to the Bitcoin Core 0.21.1 software.
Price Action:&nbsp;Bitcoin traded 3.3% lower at $35,900.28 at press time on Sunday.
Read Next:&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/21/06/21360416/marathon-digital-to-begin-signaling-for-bitcoin-taproot-activation-heres-what-that-means">Marathon Digital To Begin Signaling For Bitcoin Taproot Activation: Here&#39;s What That Means</a>

Bitcoin Set For Biggest Upgrade In Years As Taproot Gets The 90% Mandate

<ul>
<li>Hedge fund Mudrick Capital lost 10% in just a few days amid a surge in&nbsp;AMC Entertainment Holdings Inc&#39;s&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amc#NYSE">AMC</a>) stock price, the&nbsp;<a href="https://www.wsj.com/articles/amc-bet-by-hedge-fund-unravels-thanks-to-meme-stock-traders-11623431320?mod=hp_lead_pos5" target="_blank">Wall Street Journal</a>&nbsp;reported.</li>

<li>The fund is still up 12% year-to-date, while shares of AMC are up more than 2000% year-to-date.</li>

<li>Earlier this month, Mudrick Capital announced that it purchased $230.5 million of AMC shares directly from the company at $27.12 per share. The fund later<a href="https://www.benzinga.com/news/21/06/21376226/mudrick-capital-cashes-out-of-overvalued-amc-entertainment-investment-just-hours-after-buying-in-rep">&nbsp;sold&nbsp;them</a> at a profit.</li>

<li>Mudrick reportedly decided to cash out after it determined that AMC Entertainment&#39;s <a href="http://www.benzinga.com/news/21/06/21403655/missing-out-on-massive-amc-stock-surge-mudrick-capital-says-has-no-regrets-on-selling-nypost">shares are &quot;overvalued&quot;</a> and as it values businesses based on fundamentals.</li>

<li>The runaway spike&nbsp;occurred on June 2, when AMC shares rose as much as 127% to $72.62.</li>

<li>The losses for Jason Mudrick&#39;s fund&nbsp;primarily came&nbsp;from it selling&nbsp;AMC call options&nbsp;at $40 each, as per WSJ.</li>

<li>AMC&#39;s stock price blew past $40 on June 2, with an intraday high of $72.62.&nbsp;Call option prices soared amid frenzy trading and later cost the fund millions of losses. Mudrick decided to exit the AMC debt and derivative positions the next day in an internal meeting conducted on the evening of June 1, WSJ reported.</li>

<li>The fund made a 5% return on the debt and, after accounting for its options trade, the fund incurred a net loss of about 5.4% on AMC.</li>

<li>Mudrick had previously invested in AMC as it navigated a difficult period during the COVID-19 pandemic that forced the closure of its theatres.</li>

<li>Earlier this year, investors on Reddit&#39;s WallStreetBets form led a short squeeze in&nbsp;GameStop Corporation&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gme#NYSE">GME</a>), which caused short sellers to lose billions. AMC <a href="https://www.benzinga.com/news/21/06/21402359/amc-dizzying-rally-on-wednesday-took-companys-valuation-rocketing-past-rival-stonk-gamestop">overtook GameStop</a> in terms of market valuation earlier this month with a sudden surge.</li>

<li>Photo<a href="https://commons.wikimedia.org/wiki/File:AMC,_Theaters,_Plainville,_CT.jpg">&nbsp;via Wikimedia</a>.&nbsp;</li>
</ul>

Hedge Funds

AMC Stock Surge Caused 10% Loss For Mudrick Capital In Span Of Few Days: WSJ

<ul>
<li>Amazon.com, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amzn#NASDAQ">AMZN</a>) founder, Jeff Bezos&#39; Blue Origin, held&nbsp;a live auction on Saturday for a seat on its first spaceflight trip next month.</li>

<li>The live auction began at 1 p.m. EDT and lasted a few minutes. The bidding began at $4.8 million. The&nbsp;winning bid was that of $28 million<a href="https://www.youtube.com/watch?v=JUcQmETFmds">.</a>&nbsp;The name of the winner is expected to be disclosed in the coming weeks.<iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" frameborder="0" height="505" src="https://www.youtube.com/embed/JUcQmETFmds" width="650"></iframe></li>
</ul>
<ul>
<li>The auction kicked off on May 5 with sealed bids and continued till June 10.&nbsp;</li>

<li>According to Blue Origin, it got entries from more than 6,000 people from 143 countries.&nbsp;</li>

<li>The winner will then get one of the six seats on Blue Origin&#39;s first flight, which is currently set for July 20, and fly on the spacecraft with <a href="https://www.benzinga.com/news/21/06/21448828/jeff-bezos-will-travel-to-space-on-blue-origin-flight">Jeff Bezos</a><a href="http://www.benzinga.com/news/21/06/21448828/jeff-bezos-will-travel-to-space-on-blue-origin-flight"> and his brother</a> for 11 minutes. It isn&#39;t clear if the other three seats will be occupied.&nbsp;</li>

<li>The trip in the 60-foot-tall suborbital rocket will take the crew 62 miles (100 kilometers) above the Earth&#39;s surface.</li>

<li>The Blue Origin launch is set for Launch Site One in Texas.</li>

<li>Bezos&#39;s space exploration company&nbsp;competes with Richard Branson&#39;s&nbsp;Virgin Galactic Holdings Inc&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spce#NYSE">SPCE</a>)&nbsp;and Tesla Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) CEO Elon Musk&#39;s SpaceX.</li>

<li>The money raised from this auction will go towards Blue Origin&#39;s foundation, which the company says will contribute towards the development of life in space and inspire future generations to pursue careers in science.</li>

	&nbsp;
<li>&nbsp;</li>
</ul>
Photo courtesy of Blue Origin.

Travel

Tech

SPCE

Jeff Bezos' Blue Origin Auctions Seat On First Spaceflight For $28M

<img alt="Fintech Header" src="https://cdn2.hubspot.net/hub/2786381/hubfs/Fintech%20Header.png?upscale=true&amp;width=800&amp;upscale=true&amp;name=Fintech%20Header.png" />
<a href="https://www.benzinga.com/fintech/21/06/21484720/atom-finance-launches-white-labeled-data-experiences-partners-with-inter?utm_campaign=Fintech%20-%20BZ%20Fintech%20Daily%20Beat&amp;utm_source=hs_email&amp;utm_medium=email&amp;_hsenc=p2ANqtz--7d34td2joZJNXk7Pb4Q1RM96gHIulTwg--sTASuhbIEiaAkm5Dx9RD-M_rHDrwo_0WiXP">Atom Finance Launches White-Labeled Data Experiences, Partners With Inter</a> 
Atom Finance, a modern financial knowledge platform, announced its first product integration partnership with Inter, a digital platform for banking, shopping, insurance, and investments.
<img src="https://cdn2.hubspot.net/hub/2786381/hubfs/Atom.png?upscale=true&amp;width=800&amp;upscale=true&amp;name=Atom.png" />
<a href="https://www.benzinga.com/fintech/21/06/21484846/public-launches-brand-campaign-focused-on-community-long-term-stability?utm_campaign=Fintech%20-%20BZ%20Fintech%20Daily%20Beat&amp;utm_source=hs_email&amp;utm_medium=email&amp;_hsenc=p2ANqtz--7d34td2joZJNXk7Pb4Q1RM96gHIulTwg--sTASuhbIEiaAkm5Dx9RD-M_rHDrwo_0WiXP">Public Launches Brand Campaign Focused On Community, Long-Term Stability</a> 
In light of the commission-free trading revolution and speculative commentary on online forums like WallStreetBets, Public.com launched a new brand identity and campaign, honing in on proper portfolio building, wealth creation, and preservation.
<img src="https://cdn2.hubspot.net/hub/2786381/hubfs/app-social_feed_0.png?upscale=true&amp;width=800&amp;upscale=true&amp;name=app-social_feed_0.png" />
<a href="https://www.benzinga.com/fintech/21/06/21423204/fintech-spotlight-startup-infinite-sweeps-develops-ai-driven-option-orderflow-tool?utm_campaign=Fintech%20-%20BZ%20Fintech%20Daily%20Beat&amp;utm_source=hs_email&amp;utm_medium=email&amp;_hsenc=p2ANqtz--7d34td2joZJNXk7Pb4Q1RM96gHIulTwg--sTASuhbIEiaAkm5Dx9RD-M_rHDrwo_0WiXP">Fintech Spotlight: Startup Infinite Sweeps Develops AI-Driven Option Orderflow Tool</a> 
In recognition of those disruptive innovators creating positive and diverse change within the financial services space, Benzinga spoke with John Michaelis, Arnav Pangasa, and Sohil Kollipara, founders at Infinite Sweeps.
<img src="https://cdn2.hubspot.net/hub/2786381/hubfs/cover_photo_28.png?upscale=true&amp;width=800&amp;upscale=true&amp;name=cover_photo_28.png" />
<a href="https://www.benzinga.com/markets/cryptocurrency/21/06/21421965/professional-fighters-league-announces-first-mma-nfts?utm_campaign=Fintech%20-%20BZ%20Fintech%20Daily%20Beat&amp;utm_source=hs_email&amp;utm_medium=email&amp;_hsenc=p2ANqtz--7d34td2joZJNXk7Pb4Q1RM96gHIulTwg--sTASuhbIEiaAkm5Dx9RD-M_rHDrwo_0WiXP">Professional Fighters League Announces First MMA NFTs</a> 
The Professional Fighters League (PFL), a fast-growing and innovative sports league, formally announced the first official digital collectibles partnership for an MMA organization.
<img src="https://cdn2.hubspot.net/hub/2786381/hubfs/copy_of_courtesy_photo_1_7_0_0.png?upscale=true&amp;width=800&amp;upscale=true&amp;name=copy_of_courtesy_photo_1_7_0_0.png" />
<a href="https://www.benzinga.com/news/earnings/21/06/21421807/moneylion-announces-q1-earnings-results-growth-expectations?utm_campaign=Fintech%20-%20BZ%20Fintech%20Daily%20Beat&amp;utm_source=hs_email&amp;utm_medium=email&amp;_hsenc=p2ANqtz--7d34td2joZJNXk7Pb4Q1RM96gHIulTwg--sTASuhbIEiaAkm5Dx9RD-M_rHDrwo_0WiXP">MoneyLion Announces Q1 Earnings Results, Growth Expectations</a> 
In providing American&rsquo;s better access to modern mobile banking, investing, cash management, and credit building, MoneyLion&#39;s customer base grew 80% in the first quarter of 2021. Revenues also grew, amid a 204% increase in originations, to $188.7 million, compared to $62 million in the same period last year.
<img src="https://cdn2.hubspot.net/hub/2786381/hubfs/roarmoney_923a2aa5_0.jpeg?upscale=true&amp;width=800&amp;upscale=true&amp;name=roarmoney_923a2aa5_0.jpeg" />
<a href="https://www.benzinga.com/fintech/21/06/21401292/fintech-spotlight-yieldstreet-taps-100m-series-c-to-bolster-new-era-of-investing?utm_campaign=Fintech%20-%20BZ%20Fintech%20Daily%20Beat&amp;utm_source=hs_email&amp;utm_medium=email&amp;_hsenc=p2ANqtz--7d34td2joZJNXk7Pb4Q1RM96gHIulTwg--sTASuhbIEiaAkm5Dx9RD-M_rHDrwo_0WiXP">Fintech Spotlight: Yieldstreet Taps $100M Series C To Bolster New Era Of Investing</a> 
Yieldstreet, a platform that enables millions of people to generate income from investments previously reserved for institutions and the ultrawealthy, raised $100 million in a Series C round led by Tarsadia Investments.
<img src="https://cdn2.hubspot.net/hub/2786381/hubfs/pexels-sevenstorm-juhaszimrus-443383_0.jpeg?upscale=true&amp;width=800&amp;upscale=true&amp;name=pexels-sevenstorm-juhaszimrus-443383_0.jpeg" />
<a href="https://www.benzinga.com/fintech/21/06/21381040/meet-tradestation-backed-aries-a-data-focused-broker-built-by-and-for-traders?utm_campaign=Fintech%20-%20BZ%20Fintech%20Daily%20Beat&amp;utm_source=hs_email&amp;utm_medium=email&amp;_hsenc=p2ANqtz--7d34td2joZJNXk7Pb4Q1RM96gHIulTwg--sTASuhbIEiaAkm5Dx9RD-M_rHDrwo_0WiXP">Meet TradeStation-Backed Aries, A Data-Focused Broker Built By And For Traders</a> 
Aries, a retail-focused brokerage built by and for traders, is set to launch globally this summer.
In light of the company&rsquo;s rapid growth in popularity, Benzinga chatted with founder and CEO Reda Falih regarding motivations, products and timelines.
<img src="https://cdn2.hubspot.net/hub/2786381/hubfs/firmbee-com-spvhcbuki6e-unsplash.jpeg?upscale=true&amp;width=800&amp;upscale=true&amp;name=firmbee-com-spvhcbuki6e-unsplash.jpeg" />
<a href="https://www.benzinga.com/fintech/21/06/21382013/fintech-spotlight-how-tatatu-rewards-content-producers-consumers?utm_campaign=Fintech%20-%20BZ%20Fintech%20Daily%20Beat&amp;utm_source=hs_email&amp;utm_medium=email&amp;_hsenc=p2ANqtz--7d34td2joZJNXk7Pb4Q1RM96gHIulTwg--sTASuhbIEiaAkm5Dx9RD-M_rHDrwo_0WiXP">Fintech Spotlight: How TaTaTu Rewards Content Producers, Consumers</a> 
TaTaTu, a new way for users to value and earn rewards for personal data, created the first sharing economy of data on its social media platform, available on desktop and mobile.
As part of the development, Benzinga chatted with CEO and founder Andrea Iervolino.
<img src="https://cdn2.hubspot.net/hub/2786381/hubfs/cover_photo_27.png?upscale=true&amp;width=800&amp;upscale=true&amp;name=cover_photo_27.png" />
<a href="https://www.benzinga.com/fintech/21/06/21378345/tradovate-offers-commission-free-access-to-new-futures-exchange-fairx?utm_campaign=Fintech%20-%20BZ%20Fintech%20Daily%20Beat&amp;utm_source=hs_email&amp;utm_medium=email&amp;_hsenc=p2ANqtz--7d34td2joZJNXk7Pb4Q1RM96gHIulTwg--sTASuhbIEiaAkm5Dx9RD-M_rHDrwo_0WiXP">Tradovate Offers Commission-Free Access To New Futures Exchange, FairX</a> 
As part of a vision to change the futures industry through technology and pricing innovation, Tradovate announced it will be one of the first brokers to offer futures trading on FairX, a new CFTC-regulated futures exchange slated to launch this month.
<img src="https://cdn2.hubspot.net/hub/2786381/hubfs/pexels-photo-6801874_0.jpeg?upscale=true&amp;width=800&amp;upscale=true&amp;name=pexels-photo-6801874_0.jpeg" />
<a href="https://www.benzinga.com/general/sports/21/06/21480403/exclusive-how-floyd-mayweather-jr-grew-his-boxing-franchise-and-legacy-during-the-pandemic?utm_campaign=Fintech%20-%20BZ%20Fintech%20Daily%20Beat&amp;utm_source=hs_email&amp;utm_medium=email&amp;_hsenc=p2ANqtz--7d34td2joZJNXk7Pb4Q1RM96gHIulTwg--sTASuhbIEiaAkm5Dx9RD-M_rHDrwo_0WiXP">EXCLUSIVE: How Floyd Mayweather Jr. Grew His Boxing Franchise And Legacy During The Pandemic</a> 
On June 6, YouTube star Logan Paul and professional boxer Floyd Joy Mayweather Jr. went head to head in an exhibition at the Hard Rock Stadium in Miami. The event lasted for eight rounds of 3 minutes each, and no official winner was read.
In light of the high-dollar exhibition round, Benzinga had the opportunity to sit down and speak with James Williams, CEO at Mayweather Boxing + Fitness, as well as actor and longtime Mayweather friend Cuba Gooding Jr. to talk about Mayweather&rsquo;s brand and vision to disrupt the fitness industry.
<img src="https://cdn2.hubspot.net/hub/2786381/hubfs/james_williams_image_-_crop_to_use_as_main_photo_698_459_82_int_c1-1.jpeg?upscale=true&amp;width=800&amp;upscale=true&amp;name=james_williams_image_-_crop_to_use_as_main_photo_698_459_82_int_c1-1.jpeg" />
<a href="https://www.benzinga.com/news/21/06/21504281/exclusive-psychedelics-pioneer-j-r-rahn-unpacks-decision-to-leave-mindmed-as-ceo?utm_campaign=Fintech%20-%20BZ%20Fintech%20Daily%20Beat&amp;utm_source=hs_email&amp;utm_medium=email&amp;_hsenc=p2ANqtz--7d34td2joZJNXk7Pb4Q1RM96gHIulTwg--sTASuhbIEiaAkm5Dx9RD-M_rHDrwo_0WiXP">EXCLUSIVE: Psychedelics Pioneer J.R. Rahn Unpacks Decision To Leave MindMed As CEO</a> 
Mind Medicine (MindMed) Inc, a biotech company focused on the field of psychedelics, formally announced this week that J.R. Rahn, the company&rsquo;s co-founder and CEO, would step down.
Benzinga spoke with Rahn on what the transition means for MindMed, the industry and himself.
<img src="https://cdn2.hubspot.net/hub/2786381/hubfs/cover_photo_1_7.png?upscale=true&amp;width=800&amp;upscale=true&amp;name=cover_photo_1_7.png" />

Fintech Focus Roundup For June 13, 2021

&nbsp;
<ul>
<li>On Friday,&nbsp;Apple Inc&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aapl#NASDAQ">AAPL</a>) confirmed a New York Times report that the Department of Justice (DOJ) sent a request in February 2018 and demanded metadata on 73 phone numbers and 36 email addresses,&nbsp;<a href="https://www.reuters.com/technology/apple-tightens-legal-request-rules-after-justice-department-targets-lawmakers-2021-06-11/" target="_blank">Reuters</a>&nbsp;reports.&nbsp;</li>

<li>Apple said it has tightened some of its rules for responding to legal requests after the DOJ during Donald Trump&#39;s presidency subpoenaed it for information on Democratic lawmakers.</li>

<li>The company said it has instituted a limit of 25 identifiers such as email addresses or phone numbers per legal request.</li>

<li>According to the report, Apple released only basic &quot;account subscriber information&quot; such as names, addresses, email addresses, and telephone numbers and connection logs and IP addresses in response to the DOJ request.</li>

<li>The company said that it limited the information it provided to metadata and account subscriber information and did not provide any content such as emails.</li>

<li>The inspector from the justice department,&nbsp;General Michael Horowitz, has said that &quot;he will investigate the department&#39;s efforts under Trump to seize the communications data of lawmakers and members of the news media.&quot;</li>

<li>On Thursday, the New York Times reported the DOJ had&nbsp;<a href="https://www.benzinga.com/government/21/06/21526928/trump-government-summoned-apple-to-investigate-information-leaks-reuters" target="_blank">subpoenaed&nbsp;</a>Apple for data from the accounts of at least two Democrats on the House of Representatives Intelligence Committee to investigate classified information leaks.&nbsp;</li>

<li>Apple has said that it received the subpoena from the Justice Department on Feb. 6, 2018, but it contained no information about who the investigation was targeting or why.&nbsp;</li>

<li>In a statement, Apple said that it believes similar requests were sent to other technology companies and internet service providers.</li>
	&nbsp;
</ul>
Read Next:&nbsp;<a href="https://www.benzinga.com/news/21/04/20475964/snapchat-risks-apples-wrath-with-attempts-at-skirting-new-privacy-rules-ft">Snapchat Risks Apple&#39;s Wrath With Attempts At Skirting New Privacy Rules: FT</a>
&nbsp;

Politics

Legal

Apple Says It Hardened Rules On Legal Requests After Trump Administration's Subpoena

-Sky News
<a href="https://news.sky.com/story/branson-plots-3bn-spac-merger-to-launch-virgin-orbit-onto-stock-market-12330845" title="https://news.sky.com/story/branson-plots-3bn-spac-merger-to-launch-virgin-orbit-onto-stock-market-12330845">https://news.sky.com/story/branson-plots-3bn-spac-merger-to-launch-virgin-orbit-onto-stock-market-12330845</a>

Rumors

NGCA

Richard Branson in Talks to Take Virgin Orbit Public Through Merger with SPAC NextGen Acquisition II Corp

Dogecoin (DOGE) co-creator Billy Markus shared his thoughts on Tesla Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) CEO Elon Musk and others&rsquo; efforts to advance and develop the meme coin.
What Happened: Musk had said in May that he was working with &ldquo;Doge devs to improve system transaction efficiency.&rdquo; He had termed it <a href="https://www.benzinga.com/markets/cryptocurrency/21/05/21119489/elon-musk-working-with-dogecoin-devs-to-improve-system-transaction-efficiency" style="text-decoration-line:none">&ldquo;potentially promising&rdquo;</a> at the time.
On&nbsp;the development front, Markus told Benzinga that he was &ldquo;not super excited about people talking about doing things, only people actually doing things.&rdquo; He said he would see &ldquo;how it plays out.&rdquo;
See Also: <a href="https://www.benzinga.com/money/how-to-buy-dogecoin-doge/" style="text-decoration-line:none">How to Buy Dogecoin (DOGE)</a>
The Dogecoin co-creator made it clear that his comments were not a &ldquo;knock on elon or anyone in particular.&rdquo; He said this is just his general feeling about software advancement.
DOGE traded 4.59% higher at $0.308 at press time over 24 hours. The cryptocurrency is down 4.68% against both&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment/" style="text-decoration-line:none">Bitcoin</a> (BTC) and&nbsp;Ethereum (ETH).
BTC traded 4.7% lower at $35,531.15 at press time, while ETH traded 3.19% higher at $2,385.22.
Why It Matters: Musk also asked his followers on Twitter Inc&rsquo;s (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/twtr#NASDAQ">TWTR</a>) platform last month to <a href="https://www.benzinga.com/markets/cryptocurrency/21/05/21269336/elon-musk-might-reconsider-his-stance-on-bitcoin-mining-asks-followers-to-help-dogecoin-de" style="text-decoration-line:none">submit ideas for DOGE development</a> on GitHub and Reddit.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/21/05/21291152/elon-musks-starlink-can-help-scale-up-dogecoin-without-protocol-changes-proposes-researche" style="text-decoration-line:none">Elon Musk&#39;s Starlink Can Help Scale Up Dogecoin Without Protocol Changes, Proposes Researcher</a>
The Tesla CEO admitted in May that he does not have a similar role in Dogecoin and that his ability to &ldquo;<a href="https://www.benzinga.com/markets/cryptocurrency/21/05/21290616/elon-musk-says-he-isnt-the-doge-ceo-ability-to-take-action-is-limited" style="text-decoration-line:none">take action is limited</a>.&rdquo;
Last month, <a href="https://www.benzinga.com/markets/cryptocurrency/21/02/19606989/what-is-cardano">Cardano</a> (ADA) creator and Ethereum co-creator Charles Hoskinson suggested a <a href="https://www.benzinga.com/markets/cryptocurrency/21/05/21190100/elon-musk-gets-schooled-by-ethereum-co-founder-on-how-to-improve-dogecoin" style="text-decoration-line:none">plan of action to &ldquo;fix&rdquo; Dogecoin</a>.&nbsp;&nbsp;
Vitalik Buterin, another co-creator of Ethereum, though see&rsquo;s Musk&rsquo;s plans of <a href="https://www.benzinga.com/markets/cryptocurrency/21/05/21250654/why-ethereum-co-founder-sees-elon-musks-plan-for-scaling-dogecoin-as-infeasible" style="text-decoration-line:none">scaling up DOGE as infeasible</a>.
Buterin said this month that he loves Dogecoin and said that a<a href="https://www.benzinga.com/markets/cryptocurrency/21/06/21424614/vitalik-buterin-says-he-loves-doge-suggests-dogecoin-ethereum-collaboration-for-scalabilit" style="text-decoration-line:none"> Doge-to-Ethereum bridge</a> would be &ldquo;amazing.&rdquo;
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/21/06/21485890/vitalik-buterin-is-a-dogecoin-hodler-says-meme-crypto-has-proved-one-of-best-investments" style="text-decoration-line:none">Vitalik Buterin Is A Dogecoin Hodler, Says Meme Crypto Has Proved One Of &#39;Best Investments&#39;</a>

Exclusives

Interview

TWTR

EXCLUSIVE: Dogecoin Co-Creator On Development Efforts Says 'No Knock On Elon,' Others But Actions Speak Louder Than Words

What Happened: Ken Moelis, billionaire investor and head of global investment bank Moelis &amp; Co (NYSE:&nbsp;MC) said he had&nbsp;been watching the cryptocurrency space carefully.
When asked whether he was considering a move into the space in an interview with <a href="https://www.bloomberg.com/news/articles/2021-06-08/moelis-likens-crypto-to-gold-rush-watches-for-opportunities?utm_medium=social&amp;utm_content=crypto&amp;utm_source=twitter&amp;utm_campaign=socialflow-organicflow-organic" style="color:#0563c1; text-decoration:underline">Bloomberg</a>, Moelis said, &ldquo;Maybe on the personal side, definitely on the business side, we are focused on having expertise and we do.&rdquo;
Moelis went on to say that &ldquo;It&rsquo;s a big market and there&rsquo;s a lot of capital in there, there&rsquo;s a lot of projects in the space&hellip;its like the Gold Rush of 1858.&rdquo;
According to him, Moelis is in the business of providing people with the &ldquo;picks and shovels&rdquo; and hence should know what people want&nbsp;and what tools they need to be successful.
For the moment, Moelis plans to watch the space and continue to learn, saying, &ldquo;I&rsquo;m trying to keep track of it, and stay up to speed with it and I wouldn&rsquo;t say I&rsquo;m a total believer or a total non-believer.&rdquo;
Read also:&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/21/06/21488769/berkshire-hathaway-invests-500m-in-brazilian-digital-bank-nubank">Berkshire Hathaway Invests $500M In Brazilian Digital Bank Nubank</a>
The investment banker also commented on the meme-stock craze, where retail investors have benefited immensely from holding positions in stocks like GameStop Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gme#NYSE">GME</a>) and AMC Entertainment Holdings Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amc#NYSE">AMC</a>).
&quot;They&#39;re just having fun - I think 70 to 80% of this is fun,&quot; he said. &quot;When you go to a casino, the most boisterous, loudest craps table is always the one where everyone runs over because someone has made their point, they&#39;ve predicted something.&quot;
Price Action:&nbsp;Moelis &amp; Company stock closed at $54.64, 1.22%.
Bitcoin gained 0.55% during the day and stood at&nbsp;$36,855&nbsp;at press time.
The entire crypto market lost 2.4% over the last 24-hours was at&nbsp;$1.54 trillion&nbsp;as of press time.

Management

Billionaire Ken Moelis Is Watching The Crypto Space, Compares It To Gold Rush Of 1848

The <a href="https://e3expo.com/">E3 Expo</a> is one of the largest video game conference held every year. This year&#39;s event will be held virtually and viewers can tune in for free to get presentations from some of the largest gaming companies and also get gameplay demo videos.
The event is titled &quot;Online. Interactive. Worldwide. Game On.&quot; for 2021.&nbsp;
Microsoft: One of the largest gaming companies with its Xbox console and gaming divisions, Microsoft Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/msft#NASDAQ">MSFT</a>) is among the largest E3 presenters. Viewers are looking forward to seeing Microsoft present with Bethesda, which it&nbsp;acquired, together for the first time.
Microsoft could unveil more details on the Xbox Game Pass and the reasons why gamers should be paying monthly for exclusive games from the company.
Bethesda could highlight its lineup in The Elder Scrolls&nbsp;franchise and could also discuss its upcoming space,&nbsp;the RPG Starfield,&nbsp;one of its first new intellectual properties in years.
After being delayed from a release along with the Xbox Series X, Halo Infinite&nbsp;has been delayed multiple times. The game could be a highlight from Microsoft at the event.
Nintendo: One of the biggest companies to watch at E3 is Nintendo Co., Ltd. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/ntdoy#OTC">NTDOY</a>). The company could show more gameplay from upcoming highly anticipated games such as&nbsp;Metroid Prime 4,&nbsp;Splatoon 3,&nbsp;Pokemon Brilliant Diamond,&nbsp;Pokemon Shining Pearl&nbsp;and Pokemon Legends: Arceus.
Viewers will also be hoping for any news or gameplay on the highly anticipated Breath of the Wild&nbsp;sequel in the Zelda series.
Nintendo could also introduce the Nintendo Switch Pro gaming console. The new console is rumored to have a larger OLED screen and would be the next version of the bestselling console.
Ubisoft: Gaming studio Ubi Soft Entertainment (OTC: <a class="ticker" href="https://www.benzinga.com/stock/ubsfy#OTC">UBSFY</a>) will hold a panel at E3 that could include updates on several upcoming games. The footage could be shown from games such as Far Cry 6,&nbsp;Rainbow Six: Quarantine&nbsp;and Assassin&rsquo;s Creed Valhalla.&nbsp;The company could also surprise with some new announcements or gameplay from games for the first time.
Related Link: <a href="https://www.benzinga.com/news/21/02/19884348/pokemon-announces-highly-anticipated-diamond-and-pearl-remakes-why-investors-should-watch-nintendo-s">Pokemon Announces Highly Anticipated Diamong And Pearl Remakes: Why Investors Should Watch Nintendo&#39;s Stock&nbsp;</a>
Capcom: Gaming studio Capcom ADR&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/ccoey#OTC">CCOEY</a>) is presenting at E3 and could show off details and gameplay from some of the most well-known gaming franchises like Monster Hunter and Resident Evil.
Viewers could also get a look at Pragmata, a sci-fi game expected to be released in 2023. Capcom had hinted earlier that gameplay could be coming soon for Pragmata and E3 could be the perfect place to make its debut.
Galaxy Digital: Blockchain and digital asset investment company Galaxy Digital Holdings Ltd&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/brphf#OTC">BRPHF</a>) is a stock to watch with its ties to a company that could get some new interest because of&nbsp;the E3 event.
Mythical Games is a gaming studio using playable <a href="https://www.benzinga.com/money/what-is-a-non-fungible-token-nft/">non-fungible tokens</a>. The company&rsquo;s Blankos Block Party&nbsp;game was called a &ldquo;Fall Guys meets Roblox meets Funko Pop&rdquo; by <a href="https://techcrunch.com/2021/06/09/mythical-games-raises-75m-to-build-an-nft-game-engine/">TechCrunch </a>recently.
The game allows users to buy and sell items through a marketplace living on a private blockchain. The items can&rsquo;t be re-sold on public marketplaces, which could keep more revenue in-house for Mythical Games.
An open beta for Blankos Block Party&nbsp;has seen players hold more than&nbsp;100,000 NFT in the open-world playable NFT game.
The social gaming aspects of the game along with the interest in NFTs could make this a future hit. The company recently <a href="https://venturebeat.com/2021/06/09/mythical-games-raises-75-million-for-blankos-block-party-game-and-playable-nfts/">raised </a>$75 million in funding with investments from Gary Vaynerchuk&rsquo;s VaynerFund and existing investor Galaxy Digital.
Mythical Games will present on Monday,&nbsp;June 14 and will also have a NFT Twitch drop.
Others to Watch: Other companies presenting include Square Enix (OTC: <a class="ticker" href="https://www.benzinga.com/stock/sqnny#OTC">SQNNY</a>), Sony Group&nbsp;Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sony#NYSE">SONY</a>), Sega Sammy Holdings Inc (OTC: <a class="ticker" href="https://www.benzinga.com/stock/sgamy#OTC">SGAMY</a>), Take-Two Interactive Software (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttwo#NASDAQ">TTWO</a>), Verizon Communications Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vz#NYSE">VZ</a>), NetEase Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ntes#NASDAQ">NTES</a>) and SK Telecom Co Ltd (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/skm#NYSE">SKM</a>).
(Photo by <a href="https://unsplash.com/@jeshoots?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">JESHOOTS.COM</a> on <a href="https://unsplash.com/s/photos/video-games?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">Unsplash</a>)
<iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" frameborder="0" height="315" src="https://www.youtube.com/embed/78hw4-19bk8" width="560"></iframe>

Penny Stocks

Events

Movers

BRPHF

CCOEY

MSFT

NTDOY

NTES

SGAMY

Sony Group Corporation American Depositary Shares

SONY

SQNNY

TTWO

UBSFY

E3 2021: 12 Stocks To Watch For The Year's Biggest Video Game Event

&ldquo;Cannibble = Cannabis + Nibble&rdquo; says Israeli food technology startup <a href="https://cannibble.world">Cannibble Foodtech LTD</a>, a developer &amp; manufacturer of powder mix food, beverages, nutritional supplements, and spices infused with active cannabinoids or hemp seeds. Cannibble was founded in Aug 2018 by a group of individuals with experience in the fields of food development/sales and cannabis expertise.
&ldquo;Our team has more than 30 years of experience in developing and marketing edibles worldwide. Our mission is to create fun powder food products enhanced with cannabis. We aim to become a leader in the cannabis edible markets and to create a new &lsquo;Canna-food&rsquo; segment for recreational markets.&rdquo;
Having developed proprietary formulas to enhance powder-based edibles with active Cannabinoids, Cannibble has already raised approximately $2.5M USD for the development and implementation of its product line. A unique THC line of products is expected to be launched in Canada during Q2-2021.
The company completed the development of three families of revolutionary formulations for new premixed powder food products infused with cannabis and hemp-derived ingredients. These families of products cover the entire spectrum of cannabis edibles consumption today with Hemp Seeds, Oils, Protein and flower, CBD-based products, and THC-based products for the adults&rsquo; recreational market according to local regulations and policies.&nbsp;&nbsp;
&ldquo;Our leading house brand is called &lsquo;The Pelicann&rsquo; and presents the following families of products, all available to consumers today in several locations in the USA and soon in Canada. The products offer a full range of cannabis-infused products.&rdquo;
<h2>New Frontiers of Cannabis</h2>
Cannibble is additionally finishing up a crowd-funding investment round for its Pelicann product line up through FrontFundr <a href="https://www.frontfundr.com/cannibble">here</a>. The range of products includes:&nbsp;
<ul>
<li>Powders for making shakes with CBD, THC, or hemp in both standard and sports targeted protein options.</li>
<li>Mixes for baked goods with CBD, THC, or hemp.</li>
<li>Pure or blended spice mixes available with CBD or THC.</li>
<li>And microwave instant popcorn mixes available with CBD or THC.</li>
</ul>
The Cannibble edibles containing CBD are mainly for the wellness and health markets while those containing THC are for adults&#39; recreational use. The hemp seeds (which are derived as seed oils, protein and flower) are products that are most popular among consumers as a natural health ingredient.
In Benzinga&rsquo;s own home state of Michigan, growth in edibles sales have <a href="https://mjbizdaily.com/edibles-outperform-cannabis-industry-growth-in-2020-on-covid-spurred-sales-surge/">outperformed growth in regular cannabis sales for 2020</a> and shows no signs of stopping their current growth trend.

Cannabis

Food-Tech Startup Innovates in Rapidly Growing Edible Cannabis Market

<h3>GAINERS:</h3>
<ul>
<li><a href="https://quotes.benzinga.com/quote/CURR" target="_blank">CURE Pharmaceutical Hldg</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/curr#OTC">CURR</a>) shares closed up 12.33% at $0.82</li>
<li><a href="https://quotes.benzinga.com/quote/PMD" target="_blank">Psychemedics</a>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pmd#NASDAQ">PMD</a>) shares closed up 11.9% at $8.37</li>
<li><a href="https://quotes.benzinga.com/quote/GENE" target="_blank">Genetic Technologies</a>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gene#NASDAQ">GENE</a>) shares closed up 9.13% at $4.54</li>
<li><a href="https://quotes.benzinga.com/quote/NINE" target="_blank">Nine Energy Service</a>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nine#NYSE">NINE</a>) shares closed up 7.86% at $2.47</li>
<li><a href="https://quotes.benzinga.com/quote/CNGGF" target="_blank">Cann Gr</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/cnggf#OTC">CNGGF</a>) shares closed up 7.76% at $0.32</li>
<li><a href="https://quotes.benzinga.com/quote/INLB" target="_blank">Item 9 Labs</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/inlb#OTC">INLB</a>) shares closed up 7.74% at $3.48</li>
<li><a href="https://quotes.benzinga.com/quote/BMMJ" target="_blank">Body and Mind</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/bmmj#OTC">BMMJ</a>) shares closed up 7% at $0.39</li>
<li><a href="https://quotes.benzinga.com/quote/GRIN" target="_blank">Grindrod Shipping Hldgs</a>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grin#NASDAQ">GRIN</a>) shares closed up 5.98% at $10.45</li>
<li><a href="https://quotes.benzinga.com/quote/HERTF" target="_blank">Heritage Cannabis Holding</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/hertf#OTC">HERTF</a>) shares closed up 5.56% at $0.10</li>
<li><a href="https://quotes.benzinga.com/quote/IVITF" target="_blank">Invictus MD Strategies</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/ivitf#OTC">IVITF</a>) shares closed up 4.8% at $0.05</li>
<li><a href="https://quotes.benzinga.com/quote/MBII" target="_blank">Marrone Bio Innovations</a>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mbii#NASDAQ">MBII</a>) shares closed up 4.44% at $1.88</li>
<li><a href="https://quotes.benzinga.com/quote/ZYNE" target="_blank">Zynerba Pharmaceuticals</a>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zyne#NASDAQ">ZYNE</a>) shares closed up 4.06% at $5.64</li>
</ul>
<h4>LOSERS:</h4>
<ul>
<li><a href="https://quotes.benzinga.com/quote/CBWTF" target="_blank">Auxly Cannabis Group</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/cbwtf#OTC">CBWTF</a>) shares closed down 9.22% at $0.21</li>
<li><a href="https://quotes.benzinga.com/quote/CNVCF" target="_blank">BioHarvest Sciences</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/cnvcf#OTC">CNVCF</a>) shares closed down 7.8% at $0.23</li>
<li><a href="https://quotes.benzinga.com/quote/CVSI" target="_blank">CV Sciences</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/cvsi#OTC">CVSI</a>) shares closed down 5.51% at $0.44</li>
<li><a href="https://quotes.benzinga.com/quote/CNPOF" target="_blank">RIV Capital</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/cnpof#OTC">CNPOF</a>) shares closed down 4.86% at $1.31</li>
<li><a href="https://quotes.benzinga.com/quote/TGODF" target="_blank">Green Organic Dutchman</a>&nbsp;(OTC:TGOFG) shares closed down 2.84% at $0.31</li>
</ul>
<a href="https://www.benzinga.com/cannabis/stocks/">Check out a full list of cannabis stock movers in real time following this link.</a>
Lead image by Ilona Szentivanyi. Copyright: Benzinga.

BMMJ

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

CNGGF

CNPOF

CNVCF

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

CVSI

GENE

Grindrod Shipping Holdings Ltd Ordinary Shares

GRIN

HERTF

INLB

IVITF

MBII

NINE

ZYNE

Cannabis Stock Gainers And Losers From June 11, 2021

This week&rsquo;s offerings don&rsquo;t have quite the same high profile as last week&#39;s highly anticipated IPO of Coinbase Global (NASDAQ:<a class="ticker" href="/stock/COIN#NASDAQ">COIN</a>). Nevertheless, there are several exciting <a href="https://www.benzinga.com/money/how-to-invest-in-upcoming-ipos/">IPOs </a>that investors should consider this week, including UiPath and Latham Holdings.

Here is a look at the expected IPO pricings for the week of April 19.

DoubleVerify Holdings: Digital media measurement and analytics company DoubleVerify Holdings (NYSE:<a class="ticker" href="/stock/DV#NYSE">DV</a>) <a href="https://www.sec.gov/Archives/edgar/data/1819928/000104746921000920/a2243146zs-1a.htm">plans </a>to sell 13.3 million shares at a price point of $24 to $27.

The company makes security software for digital advertising and claims to have over 1,000 advertisers and publishers as partners, and more than 45 customers that each account for $1 million in annual revenue for DoubleVerify.

The company had revenue of $244 million in fiscal 2020, a year-over-year increase of 34%.

NeuroPace: Commercial-stage medical device company NeuroPace (NASDAQ:<a class="ticker" href="/stock/NPCE#NASDAQ">NPCE</a>) says it&nbsp;<a href="https://www.sec.gov/Archives/edgar/data/1528287/000162828021006852/neuropaces-1a1.htm">has </a>the first and only commercially-available, brain-responsive system to help fight seizures.

The company&rsquo;s target market is customers who have drug-resistant epilepsy. Over 3,000 patients were&nbsp;served by the company through 2020. Neuropace had revenue of $10 million in fiscal 2020 and is guiding for fiscal 2021 revenue of between $11.1 million and $11.3 million.

Over $28 billion is spent annually on epilepsy care in the United States. The company plans to sell 5.3 million shares at a price point of $15 to $17.

Related Link: <a href="https://www.benzinga.com/calendars/ipos">IPO Calendar&nbsp;</a>

UiPath: The <a href="https://www.benzinga.com/money/how-to-buy-uipath-ipo-stock/">biggest IPO</a> of the week is set to be automation company UiPath Inc (NYSE:<a class="ticker" href="/stock/PATH#NYSE">PATH</a>), with a <a href="https://www.sec.gov/Archives/edgar/data/1734722/000119312521112457/d98556ds1a.htm">planned </a>offering of 21.3 million shares at a price point of $43 to $50.

The company &ldquo;makes software robots so people don&rsquo;t have to be robots.&rdquo; The company had annual recurring revenue of $580 million in the fiscal year ended January 31, 2021, for a growth rate of 65%.&nbsp;UiPath says it has over 7,900 customers, with over 1,000 of them paying $100,000 or more annually to the company.

The company is targeting a market opportunity of $65 billion and believes its open architecture and end-to-end platform set it apart from competitors.

SkyWater Technology: Pure-play technology foundry SkyWater Technology (NASDAQ:<a class="ticker" href="/stock/SKYT#NASDAQ">SKYT</a>) <a href="https://www.sec.gov/Archives/edgar/data/1819974/000119312521112378/d26688ds1a.htm">offers </a>semiconductor development and manufacturing services, targeting&nbsp;customers in markets like advanced computing, aerospace, defense, automotive and IoT.

The company has 35 customers in its advanced technology services including L3Harris and Microsoft Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/msft#NASDAQ" style="font-size: 13px;">MSFT</a>). SkyWater was divested from Cypress Semiconductor in 2017. The company had revenue of $140.4 million in 2020.

SkyWater plans to sell 5.8 million shares at a price point of $12 to $14.

Related Link: <a href="https://www.benzinga.com/markets/cryptocurrency/21/01/18943910/10-ipos-to-watch-out-for-in-2021-including-petco-poshmark-bumble-coinbase-and-more">10 IPOs To Watch Out For In 2021 Including Petco, Poshmark, Bumble, Coinbase And More</a>

KnowBe4: Security platform KnowBe4 Inc (NASDAQ:<a class="ticker" href="/stock/KNBE#NASDAQ">KNBE</a>) is <a href="https://www.sec.gov/Archives/edgar/data/1664998/000162828021006752/knowbe4incs-1a1.htm">seeking </a>to sell 11.8 million shares at a price point of $16 to $18.

The company serves over 37,000 customers globally in markets worth $15 billion. The company had 45% revenue growth and $198 million in annual recurring revenue last year. It plans to rapidly grow its international operations, which made up 11.9% of revenue in fiscal 2020.

Zymergen: &quot;Biofacturing&quot; company Zymergen (NASDAQ:<a class="ticker" href="/stock/ZY#NASDAQ">ZY</a>) <a href="https://www.sec.gov/Archives/edgar/data/1645842/000114036121012684/nt10018776x8_s1a.htm">plans </a>to sell 13.6 million shares at a price of $28 to $31.

The company is working on bio-based products including films that could be used in rollable mobile tablet devices.

The company&rsquo;s first product, Hyaline, was launched in December 2020, and an additional 10 products are in development. The biofacturing market is worth $1.2 trillion. according to the company.

Agiliti: Healthcare service provider&nbsp;Agiliti Inc (NYSE:<a class="ticker" href="/stock/AGTI#NYSE">AGTI</a>) says it&nbsp;<a href="https://www.sec.gov/Archives/edgar/data/1749704/000119312521117046/d59213ds1a.htm">has </a>a customer base of over 7,0000 networks and that&nbsp;90% of U.S. acute and alternate care facilities are within a 100-mile radius of an Agiliti service center. The company is seeking to sell 26.3 million shares at a price point of $18 to $20.

Latham Group: A designer, manufacturer and marketer of in-ground residential pools in North America, Australia and New Zealand <a href="https://www.sec.gov/Archives/edgar/data/1833197/000110465921050187/tm2038279-13_s1a.htm">plans </a>to go public this week.

Latham Group (NASDAQ:<a class="ticker" href="/stock/SWIM#NASDAQ">SWIM</a>) plans to sell 20 million shares at a price point of $19 to $21.

The company sells fiberglass products that are more durable and use less chemicals, according to the company. Latham sold 8,700 fiberglass pools in 2020 and reported its 11th consecutive year of net sales growth.

The company had revenue of $408 million in fiscal 2020, and&nbsp;59% of it came from in-ground pool sales.&nbsp;

In 2018, the company shifted from a business-to-business model to business-to-consumer, making it&nbsp;the only pool company with a direct relationship to the homeowner, according to the company.

Fiberglass pools are still a small market in North America compared to international markets, Latham says. The company claims to have a No. 1 market-share position in all the categories it competes in for the North American market.

Photo courtesy UiPath.

IPOs

IPO Preview: UiPath Inc, KnowBe4, Zymergen, Latham Holdings Highlight Busy Week Of Offerings

There have been quite a few appealing <a href="https://www.benzinga.com/money/how-to-invest-in-upcoming-ipos/">Initial Public Offerings </a>(IPOs) available on the <a href="https://investmentfirms.com/what-is-the-stock-market/">market</a> so far this year. Here are some upcoming IPOs that investors should be watching out for.
<h2>1. Zymergen</h2>
Zymergen (NASDAQ:<a class="ticker" href="/stock/ZY#NASDAQ">ZY</a>) is a science &amp; material innovation company that partners with nature to strive to create the products of tomorrow. They design products, find the microbes to make them, and scale those products on their platform. Zymergen is poised to offer 13,600,000 shares of stock on the Nasdaq at a target price of $28.00 - $31.00 on the week of April 19th.&nbsp;
<h2>2. UiPath</h2>
UiPath (NYSE:<a class="ticker" href="/stock/PATH#NYSE">PATH</a>) is a global software company that was founded in Bucharest, Romania. Their products are used by organizations to help efficiently automate their various business processes. UiPath intends to offer 21,282,081 shares of stock at a target price of&nbsp; $43.00 - $50.00 on the week of April 19th.&nbsp;
See also: <a href="https://www.benzinga.com/money/how-to-buy-uipath-ipo-stock/">How to Buy UiPath</a>
<h2>3. SkyWater Technology</h2>
SkyWater Technology (NASDAQ:<a class="ticker" href="/stock/SKYT#NASDAQ">SKYT</a>) is a technology Foundry that specializes in advanced Innovation Engineering Services and manufacturing. They provide foundry services for mixed-signal asic and next-wave technologies. SkyWater Technology intends to offer 5,800,000 shares at a target price between $12.00 - $14.00 on the week of April 19th.&nbsp;
<h2>4. NeuroPace</h2>
NeuroPace (NASDAQ:<a class="ticker" href="/stock/NPCE#NASDAQ">NPCE</a>) is a commercial-stage medical device company that is striving to help people that suffer from epilepsy and seizures. They are based in Mountain View, California and their platform was built to help improve standard care for patients. NeuroPace is poised to offer 5,313,000 shares of stock at a target price of $15.00 - $17.00 on the week of April 19th.&nbsp;
<h2>5. Latham Group</h2>
Latham Group (NASDAQ:<a class="ticker" href="/stock/SWIM#NASDAQ">SWIM</a>) is a designer, manufacturer and marketer of in-ground residential swimming pools. They offer in-ground swimming pools, pool liners and pool covers. Latham Group is poised to offer 20,000,000 shares of stock at a target price of $19.00 - $21.00 on the Nasdaq.&nbsp;
&nbsp;

Let's Take a Look At Some Upcoming IPOs This Week

SkyWater Technology Shares Will Open For Trade At 10:35 a.m. EDT, Expected To Open For Trade After 10:45 a.m. EDT; IPO Priced At $14/Share

SkyWater Technology Shares Indicate $15 On 267K Shares

SkyWater Technology Shares Open For Trade At $15.50; IPO Priced At $14/Share

<h3>Gainers</h3>

<ul>
	<li>Welbilt, Inc. (NYSE:<a class="ticker" href="/stock/WBT#NYSE">WBT</a>) shares surged 44.5% to close at $22.58 on Wednesday after The Middleby Corporation announced plans to acquire the company.</li>
	<li>Skillz Inc. (NYSE:<a class="ticker" href="/stock/SKLZ#NYSE">SKLZ</a>) jumped 33.6% to settle at $16.76.</li>
	<li>Shineco, Inc. (NASDAQ:<a class="ticker" href="/stock/TYHT#NASDAQ">TYHT</a>) gained 31.5% to close at $6.68. Shineco, on April 14, entered into stock purchase agreements with investors.</li>
	<li>GreenBox POS (NASDAQ:<a class="ticker" href="/stock/GBOX#NASDAQ">GBOX</a>) gained 27.4% to settle at $9.72. GreenBox POS recently announced the appointment of public accounting veteran Ben Chung as its new CFO and fraud and risk management veteran Bryan Rowland as Head of Risk Management.</li>
	<li>Tiptree Inc. (NASDAQ:<a class="ticker" href="/stock/TIPT#NASDAQ">TIPT</a>) rose 26.9% to close at $14.22 after climbing 12% on Tuesday.</li>
	<li>SkyWater Technology, Inc. (NASDAQ:<a class="ticker" href="/stock/SKYT#NASDAQ">SKYT</a>) gained 26.7% to settle at $17.74 after the company priced its IPO at $14 a share.</li>
	<li>PLBY Group, Inc. (NASDAQ:<a class="ticker" href="/stock/PLBY#NASDAQ">PLBY</a>) rose 26.3% to close at $45.14. JP Morgan recently disclosed a 7.9% passive stake in PLBY Group.</li>
	<li>BioVie Inc. (NASDAQ:<a class="ticker" href="/stock/BIVI#NASDAQ">BIVI</a>) gained 26.2% to settle at $13.34.</li>
	<li>UiPath Inc. (NASDAQ:<a class="ticker" href="/stock/PATH#NASDAQ">PATH</a>) surged 23.2% to close at $69.00 as the company priced its IPO at $56 per share.</li>
	<li>inTEST Corporation (NYSE:<a class="ticker" href="/stock/INTT#NYSE">INTT</a>) shares jumped 22.2% to close at $11.66.</li>
	<li>Genius Sports Limited (NASDAQ:<a class="ticker" href="/stock/GENI#NASDAQ">GENI</a>) gained 22% to close at $19.78.</li>
	<li>Organovo Holdings, Inc. (NASDAQ:<a class="ticker" href="/stock/ONVO#NASDAQ">ONVO</a>) surged 21.2% to settle at $9.26.</li>
	<li>MicroVision, Inc. (NASDAQ:<a class="ticker" href="/stock/MVIS#NASDAQ">MVIS</a>) jumped 20.3% to settle at $12.49.</li>
	<li>Northern Genesis Acquisition Corp. (NYSE:<a class="ticker" href="/stock/NGA#NYSE">NGA</a>) gained 18.6% to close at $15.63.</li>
	<li>Williams Industrial Services Group Inc. (NYSE:<a class="ticker" href="/stock/WLMS#NYSE">WLMS</a>) gained 18.3% to settle at $4.40. The company, last month, reported Q4 results.</li>
	<li>INmune Bio, Inc. (NASDAQ:<a class="ticker" href="/stock/INMB#NASDAQ">INMB</a>) gained 18.2% to close at $13.03 after B. Riley FBR initiated coverage on the stock with a Buy rating and a price target of $29 per share.</li>
	<li>Mogo Inc. (NASDAQ:<a class="ticker" href="/stock/MOGO#NASDAQ">MOGO</a>) rose 18% to settle at $8.05.</li>
	<li>Ocugen, Inc. (NASDAQ:<a class="ticker" href="/stock/OCGN#NASDAQ">OCGN</a>) gained 17.8% to close at $6.50. Ocugen said its co-development partner Bharat Biotech announced positive results from the second interim analysis of the Phase 3 study of Covaxin, a whole virion inactivated COVID-19 vaccine candidate.</li>
	<li>Fisker Inc. (NYSE:<a class="ticker" href="/stock/FSR#NYSE">FSR</a>) rose 17.2% to settle at $15.15 in sympathy with the broader market as stocks across sectors rebound following recent selloffs.</li>
	<li>GigCapital3, Inc. (NYSE:<a class="ticker" href="/stock/GIK#NYSE">GIK</a>) gained 16.8% to settle at $9.05.</li>
	<li>Avenue Therapeutics, Inc. (NASDAQ:<a class="ticker" href="/stock/ATXI#NASDAQ">ATXI</a>) surged 16.4% to close at $4.55. The company recently announced FDA is still reviewing its NDA resubmission for IV tramadol and has not provided a decision.</li>
	<li>Metromile, Inc. (NASDAQ:<a class="ticker" href="/stock/MILE#NASDAQ">MILE</a>) gained 15.6% to close at $8.75.</li>
	<li>Excellon Resources Inc. (NYSE:<a class="ticker" href="/stock/EXN#NYSE">EXN</a>) surged 15.6% to settle at $3.19.</li>
	<li>Alterity Therapeutics Limited (NASDAQ:<a class="ticker" href="/stock/ATHE#NASDAQ">ATHE</a>) climbed 15.2% to close at $1.44.</li>
	<li>Desktop Metal, Inc. (NYSE:<a class="ticker" href="/stock/DM#NYSE">DM</a>) gained 14.6% to settle at $12.89.</li>
	<li>Sierra Metals Inc. (NYSE:<a class="ticker" href="/stock/SMTS#NYSE">SMTS</a>) rose 14.5% to close at $3.23. The company, last week, released Q1 results.</li>
	<li>Acme United Corporation (NYSE:<a class="ticker" href="/stock/ACU#NYSE">ACU</a>) rose 13.4% to close at $43.00. Acme United recently reported better-than-expected Q1 sales.</li>
	<li>TransMedics Group, Inc. (NASDAQ:<a class="ticker" href="/stock/TMDX#NASDAQ">TMDX</a>) gained 13.3% to settle at $28.36. The company recently announced the FDA advisory committee panel voted 12 to 5 that the benefits of the OCS Heart System outweigh the risks.</li>
	<li>Arrival (NASDAQ:<a class="ticker" href="/stock/ARVL#NASDAQ">ARVL</a>) rose 12.1% to close at $14.59 after dropping over 6% on Tuesday.</li>
	<li>Support.com, Inc. (NASDAQ:<a class="ticker" href="/stock/SPRT#NASDAQ">SPRT</a>) rose 11.2% to close at $3.59. Support.com recently announced the purchase of a Bitcoin mining company.</li>
	<li>Acorda Therapeutics, Inc. (NASDAQ:<a class="ticker" href="/stock/ACOR#NASDAQ">ACOR</a>) climbed 10.8% to settle at $4.60. Hearing Motley Fool named the stock a &#39;must buy.&#39;</li>
	<li>Intuitive Surgical, Inc. (NASDAQ:<a class="ticker" href="/stock/ISRG#NASDAQ">ISRG</a>) shares jumped 9.9% to settle at $891.38 after the company reported better-than-expected Q1 results.</li>
	<li>Cassava Sciences, Inc. (NASDAQ:<a class="ticker" href="/stock/SAVA#NASDAQ">SAVA</a>) gained 8.5% to close at $34.87 following Q1 earnings.</li>
	<li>Aesthetic Medical International Holdings Group Limited (NASDAQ:<a class="ticker" href="/stock/AIH#NASDAQ">AIH</a>) gained 8.4% to close at $5.80. The company recently reported better-than-expected Q4 sales results.</li>
	<li>Edwards Lifesciences Corp (NYSE:<a class="ticker" href="/stock/EW#NYSE">EW</a>) rose 6.3% to close at $95.24 after the company reported better-than-expected Q1 results and issued strong guidance.</li>
</ul>

&nbsp;

<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>Infobird Co., Ltd (NASDAQ:<a class="ticker" href="/stock/IFBD#NASDAQ">IFBD</a>) shares dipped 21.4% to close at $4.74 on Wednesday. The company&rsquo;s shares jumped over 50% on Tuesday after the company priced its IPO at $4 per share.</li>
	<li>Unique Fabricating, Inc. (NYSE:<a class="ticker" href="/stock/UFAB#NYSE">UFAB</a>) shares fell 20% to settle at $4.04 after the company swung to a loss in the fourth quarter.</li>
	<li>Digital Ally, Inc. (NASDAQ:<a class="ticker" href="/stock/DGLY#NASDAQ">DGLY</a>) fell 11.9% to close at $1.71. Former Minneapolis police officer Derek Chauvin was convicted Tuesday of second-degree murder, third-degree murder and second-degree manslaughter in the death of George Floyd, an unarmed Black man whose neck Chauvin kneeled on for more than nine minutes during an arrest last May despite Floyd&rsquo;s cries of &ldquo;I can&rsquo;t breathe!&rdquo;</li>
	<li>Esports Technologies, Inc. (NASDAQ:<a class="ticker" href="/stock/EBET#NASDAQ">EBET</a>) fell 10.2% to close at $22.50. The company recently announced the launch of its consumer platform, Gogawi, in Japan.</li>
	<li>Troika Media Group, Inc. (NASDAQ:<a class="ticker" href="/stock/TRKA#NASDAQ">TRKA</a>) fell 9.9% to settle at $2.81. Troika Media shares dipped around 25% on Tuesday after the company priced its IPO at $4.15 per share.</li>
	<li>Lava Therapeutics B.V. (NASDAQ:<a class="ticker" href="/stock/LVTX#NASDAQ">LVTX</a>) dipped 9.6% to close at $12.30. Multiple firms recently initiated coverage on the stock with a bullish rating.</li>
	<li>Brooklyn ImmunoTherapeutics, Inc. (NYSE:<a class="ticker" href="/stock/BTX#NYSE">BTX</a>) fell 9.1% to settle at $8.90.</li>
	<li>Enthusiast Gaming Holdings Inc. (NASDAQ:<a class="ticker" href="/stock/EGLX#NASDAQ">EGLX</a>) dropped 8.8% to close at $7.88.</li>
	<li>J2 Global, Inc. (NASDAQ:<a class="ticker" href="/stock/JCOM#NASDAQ">JCOM</a>) fell 8.5% to close at $118.35 after Piper Sandler downgraded the stock from Overweight to Neutral.</li>
	<li>Design Therapeutics, Inc. (NASDAQ:<a class="ticker" href="/stock/DSGN#NASDAQ">DSGN</a>) shares dropped 8.4% to settle at $19.55 on Wednesday.</li>
	<li>Planet Green Holdings Corp. (NYSE:<a class="ticker" href="/stock/PLAG#NYSE">PLAG</a>) fell 8.3% to close at $2.20.</li>
	<li>Netflix, Inc. (NASDAQ:<a class="ticker" href="/stock/NFLX#NASDAQ">NFLX</a>) dropped 7.4% to settle at $508.90. Netflix reported better-than-expected earnings and sales results for its first quarter. However, the company said it finished the quarter with 208 million paid memberships, up 14% year over year but below the company forecast of 210 million..</li>
	<li>Inotiv, Inc. (NASDAQ:<a class="ticker" href="/stock/NOTV#NASDAQ">NOTV</a>) shares fell 6.2% to close at $19.22 after the company priced its 2,647,059 share common stock offering at $17 per share.</li>
</ul>

Pre-Market Outlook

48 Biggest Movers From Yesterday

<h3>Gainers</h3>

<ul>
	<li>Brooklyn ImmunoTherapeutics, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTX#NYSE">BTX</a>) gained 51.2% to close at $24.90 on Tuesday.</li>
	<li>Urban Tea, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYT#NASDAQ">MYT</a>) rose 38.1% to settle at $4.64.</li>
	<li>Vaxart, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VXRT#NASDAQ">VXRT</a>) jumped 37.5% to settle at $8.33 on Tuesday.</li>
	<li>Tian Ruixiang Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIRX#NASDAQ">TIRX</a>) shares climbed 36.3% to settle at $16.38 on Tuesday after the company reported its financial results for the fiscal year ended October 31, 2020.</li>
	<li>Aldeyra Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALDX#NASDAQ">ALDX</a>) shares surged 33.7% to close at $14.85 as the company said it achieves statistical significance for primary endpoint and all secondary endpoints in Phase 3 INVIGORATE clinical trial of Reproxalap in allergic conjunctivitis.</li>
	<li>The Aaron&#39;s Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAN#NYSE">AAN</a>) climbed 29.3% to settle at $34.16 after the company reported better-than-expected Q1 results.</li>
	<li>First Choice Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCBP#NASDAQ">FCBP</a>) rose 27.2% to close at $30.92 after the company reported a rise in Q1 earnings.</li>
	<li>RiceBran Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIBT#NASDAQ">RIBT</a>) shares gained 26.9% to close at $1.18. RiceBran Technologies is scheduled to host a conference call on April 28th to discuss its Q1 financial results.</li>
	<li>NetSol Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTWK#NASDAQ">NTWK</a>) rose 25.3% to close at $5.40 after the company announced it signed a five-year contract worth multi-million-dollar renewal with a Japanese automotive customer in APAC.</li>
	<li>Trueblue Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBI#NYSE">TBI</a>) surged 24.9% to close at $28.80 after the company swung to a Q1 profit.</li>
	<li>Elite Education Group International Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EEIQ#NASDAQ">EEIQ</a>) gained 21.2% to close at $6.91.</li>
	<li>X Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYF#NYSE">XYF</a>) surged 18.2% to settle at $4.75.</li>
	<li>Auddia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) jumped 17.7% to close at $2.80. Auddia recently appointed Brian Hoff as Finance Chief.</li>
	<li>Esports Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBET#NASDAQ">EBET</a>) gained 16.8% to settle at $24.03. The company recently announced the launch of its consumer platform, Gogawi, in Thailand.</li>
	<li>Nymox Pharmaceutical Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYMX#NASDAQ">NYMX</a>) rose 16.6% to close at $2.46 after a company director purchased 40,000 shares at an average price of $2.08 per share.</li>
	<li>Sequential Brands Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SQBG#NASDAQ">SQBG</a>) gained 16.3% to settle at $24.00. The company recently completed the sale of the Heelys brand.</li>
	<li>Novavax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) gained 16.3% to settle at $257.67 after US President Biden mentioned the company&#39;s COVID-19 vaccine candidate and after the company&#39;s CEO met with South Korean President Moon Jae-in. Separately, the company on Friday highlighted the publication of positive Phase 2b malaria vaccine data.</li>
	<li>Crocs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CROX#NASDAQ">CROX</a>) jumped 15.3% to settle at $97.82 after the company reported better-than-expected Q1 results. Crocs said it sees Q2 sales growth of 60%-70% and FY21 sales growth of 40%-50%.</li>
	<li>Lion Group Holding Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGHL#NASDAQ">LGHL</a>) gained 14.6% to close at $2.82.</li>
	<li>Crown ElectroKinetics Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRKN#NASDAQ">CRKN</a>) surged 13.8% to settle at $4.36.</li>
	<li>DermTech, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMTK#NASDAQ">DMTK</a>) surged 11.1% to close at $45.74 after the company announced the launch DermTech PLAplusTM, its test for the enhanced early detection of melanoma.</li>
	<li>Aravive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARAV#NASDAQ">ARAV</a>) surged 11.1% to close at $5.99 as the company said first patient was dosed in Phase 3 registrational trial evaluating AVB-500 in patients with platinum resistant ovarian cancer.</li>
	<li>Afya Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFYA#NASDAQ">AFYA</a>) gained 11% to settle at $24.21 after the company announced a $150 million investment from the SoftBank Latin America Fund.</li>
	<li>United Parcel Service, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) jumped 10.4% to close at $194.13 after the company reported better-than-expected Q1 results.</li>
	<li>Mechanical Technology, Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKTY#NASDAQ">MKTY</a>) shares rose 9.7% to close at $8.50 after the company priced its 2,419,355 share common stock offering at $6.20 per unit, for proceeds of $15 million.</li>
	<li>Heidrick &amp; Struggles International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSII#NASDAQ">HSII</a>) surged 9.7% to close at $41.39 after the company reported better-than-expected Q1 results and issued Q2 sales guidance above estimates.</li>
	<li>Cullinan Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGEM#NASDAQ">CGEM</a>) shares climbed 9.4% to close at $34.67. Morgan Stanley upgraded Cullinan Oncology from Equal-Weight to Overweight.</li>
	<li>Cerecor Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERC#NASDAQ">CERC</a>) gained 8.8% to close at $2.84.</li>
	<li>Turning Point Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPB#NYSE">TPB</a>) jumped 5% to close at $50.99 after reporting strong quarterly sales.</li>
</ul>

 
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>Protagenic Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) shares tumbled 27.3% to close at $2.24 after the company priced an underwritten public offering of 3.18 million units at a public offering price of $4.15 per unit for aggregate gross proceeds of approximately $13.2 million. In connection with the offering, the company has received approval to list its common stock and warrants on the Nasdaq Capital Market.</li>
	<li>RealNetworks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNWK#NASDAQ">RNWK</a>) dropped 24.9% to settle at $2.56 after the company priced 8.25 million shares at $2.7 per share to raise $22.3 million in a secondary public offering.</li>
	<li>MicroVision, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) fell 23.8% to close at $20.16 after surging 47% on Monday. The technology company has cemented its position as a &ldquo;meme stock&rdquo; and is spiking for the second straight session based on social media momentum.</li>
	<li>Cyclerion Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCN#NASDAQ">CYCN</a>) shares fell 18% to settle at $2.56. The company recently appointed Errol De Souza, Ph.D., to Board of Directors.</li>
	<li>Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVPH#NASDAQ">RVPH</a>) fell 16.1% to close at $7.30. Reviva Pharmaceuticals shares jumped 104% on Monday after the company announced the full details of its Phase 2 trial evaluating its lead drug candidate, RP5063 (brilaroxazine), for Acute Schizophrenia. Brilaroxazine demonstrated high affinity and selectivity for key serotonin receptors (5-HT1A/2A/2B/7) through its combination of potent affinity and selectivity for target receptors implicated for schizophrenia and its comorbid symptoms.</li>
	<li>Medpace Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDP#NASDAQ">MEDP</a>) fell 14.2% to settle at $166.73 following Q1 results.</li>
	<li>SkyWater Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYT#NASDAQ">SKYT</a>) dropped 13.7% to close at $18.15. The company, last week, priced its IPO at $14 per share.</li>
	<li>PQ Group Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PQG#NYSE">PQG</a>) fell 12.8% to close at $14.57 after the company reported preliminary Q1 results and announced a secondary offering of 12,500,000 shares of common stock by selling shareholders.</li>
	<li>Sol-Gel Technologies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLGL#NASDAQ">SLGL</a>) fell 12.7% to close at $12.00 after the company issued an update on FDA review of EPSOLAY.</li>
	<li>Scienjoy Holding Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SJ#NASDAQ">SJ</a>) dipped 12.7% to settle at $9.52. The company recently announced it launched NFTs on its live-streaming platforms.</li>
	<li>Sypris Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYPR#NASDAQ">SYPR</a>) fell 12.6% to close at $3.53.</li>
	<li>Liquid Media Group Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YVR#NASDAQ">YVR</a>) dipped 12% to settle at $2.72. Liquid Media Group named Andy Wilson as Finance Chief.</li>
	<li>Amkor Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) shares dropped 11.9% to close at $21.06 after the company reported Q1 results and issued Q2 guidance.</li>
	<li>Trxade Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDS#NASDAQ">MEDS</a>) fell 11.7% to close at $4.30 after reporting a loss for its first quarter.</li>
	<li>Aligos Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGS#NASDAQ">ALGS</a>) dropped 11.7% to close at $25.71.</li>
	<li>Hydrofarm Holdings Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYFM#NASDAQ">HYFM</a>) fell 11.5% to close at $54.85. The company announced it entered into an agreement to acquire HEAVY 16 for up to $78.1 million. The company also announced the launch of a proposed public offering of common stock.</li>
	<li>iHuman Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IH#NYSE">IH</a>) fell 11.3% to close at $12.46.</li>
	<li>Mesoblast Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESO#NASDAQ">MESO</a>) fell 8.7% to close at $7.41.</li>
	<li>Cadence Design Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNS#NASDAQ">CDNS</a>) shares fell 8% to settle at $132.75 after the company reported Q1 earnings results.</li>
	<li>TriNet Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TNET#NYSE">TNET</a>) fell 7.8% to settle at $77.75 after the company posted Q1 results and issued Q2 forecast.</li>
	<li>Centene Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>) shares dropped 7.1% to close at $61.31 following Q1 results.</li>
	<li>Sphere 3D Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANY#NASDAQ">ANY</a>) fell 6.5% to close at $2.16.</li>
	<li>Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) fell 4.5% to settle at $704.74. Tesla reported better-than-expected earnings and sales for its first quarter. Production was 180,338 vehicles in the first quarter, up 76% year-over-year, while deliveries climbed 109% year-over-year to 184,877.</li>
</ul>

52 Biggest Movers From Yesterday

<h3>Gainers</h3>

<ul>
	<li>ShiftPixy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIXY#NASDAQ">PIXY</a>) jumped 33.1% to settle at $3.34 on Thursday as the company said it has been named as sponsor related to 4 SPACs.</li>
	<li>Takung Art Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TKAT#NASDAQ">TKAT</a>) surged 24.2% to close at $39.11</li>
	<li>JAKKS Pacific, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAKK#NASDAQ">JAKK</a>) gained 23.4% to close at $9.05 after the company reported better-than-expected Q1 results.</li>
	<li>Galera Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRTX#NASDAQ">GRTX</a>) climbed 22.8% to settle at $8.12 after the company announced updated results from its Phase 1/2 pilot trial of GC4419, versus placebo, in patients with locally advanced pancreatic cancer who are undergoing stereotactic body radiation therapy.</li>
	<li>Ocular Therapeutix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCUL#NASDAQ">OCUL</a>) gained 22.7% to close at $19.16. Ocular Therapeutix, reported multiple scientific presentations at the Association for Research in Vision and Ophthalmology Annual Meeting.</li>
	<li>1-800-FLOWERS.COM, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLWS#NASDAQ">FLWS</a>) jumped 20.5% to close at $29.89 after the company reported better-than-expected Q3 results.</li>
	<li>Willamette Valley Vineyards, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WVVI#NASDAQ">WVVI</a>) gained 19.6% to close at $12.25 on Thursday.</li>
	<li>SkyWater Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYT#NASDAQ">SKYT</a>) rose 16.9% to close at $21.77. The company, last week, priced its IPO at $14 per share.</li>
	<li>VEREIT, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VER#NYSE">VER</a>) jumped 16% to close at $47.88 after the company announced an all-stock merger agreement with Realty Income.</li>
	<li>MEDIROM Healthcare Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRM#NASDAQ">MRM</a>) gained 15.2% to close at $10.31.</li>
	<li>Sharps Compliance Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMED#NASDAQ">SMED</a>) surged 15% to close at $18.41 on continued upward momentum after the company reported better-than-expected Q3 EPS and sales results. Following earnings, HC Wainwright &amp; Co maintained a Buy and raised its price target from $18 to $25.</li>
	<li>Capricor Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPR#NASDAQ">CAPR</a>) shares jumped 14.9% to close at $4.54 after the company signed exclusive worldwide license agreement with Johns Hopkins University to include engineered exosomes for vaccines and therapeutics as part of the company&#39;s exosome technology portfolio.</li>
	<li>Communications Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JCS#NASDAQ">JCS</a>) gained 14.5% to close at $6.73 as the company agreed to sell its Transition Networks and Net2Edge businesses to Lantronix.</li>
	<li>Enlivex Therapeutics Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENLV#NASDAQ">ENLV</a>) surged 14.2% to settle at $12.10.</li>
	<li>Dolphin Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLPN#NASDAQ">DLPN</a>) shares rose 13.2% to close at $12.99. Dolphin Entertainment recently reported better-than-expected Q4 sales results.</li>
	<li>Century Communities, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCS#NYSE">CCS</a>) gained 13.1% to settle at $74.94 after the company reported better-than-expected Q1 EPS and sales results. The company also raised its FY21 sales guidance.</li>
	<li>GreenBox POS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GBOX#NASDAQ">GBOX</a>) surged 13.1% to close at $11.35.</li>
	<li>North American Construction Group Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOA#NYSE">NOA</a>) gained 12.5% to close at $13.28 after the company reported Q1 earnings results.</li>
	<li>Extreme Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXTR#NASDAQ">EXTR</a>) climbed 12.4% to close at $12.01. The company recently reported better-than-expected Q3 results.</li>
	<li>Summer Infant, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SUMR#NASDAQ">SUMR</a>) gained 12% to settle at $18.91.</li>
	<li>Nokia Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOK#NYSE">NOK</a>) shares jumped 11.2% to close at $4.67 after reporting upbeat Q1 results.</li>
	<li>Realogy Holdings Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLGY#NYSE">RLGY</a>) climbed 10.4% to close at $16.83 following upbeat quarterly results.</li>
	<li>Alliance Data Systems Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADS#NYSE">ADS</a>) jumped 10% to close at $118.64 following upbeat Q1 results.</li>
	<li>Vaxart, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VXRT#NASDAQ">VXRT</a>) climbed 9.1% to settle at $9.21 as the company said its founder and chief scientific officer, Sean Tucker, Ph.D., will present at the World Vaccine Congress Washington that will be held virtually from May 4-6, 2021.</li>
	<li>Bloomin&#39; Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMN#NASDAQ">BLMN</a>) rose 8.9% to settle at $31.38 after the company reported better-than-expected Q1 results.</li>
	<li>MRC Global Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRC#NYSE">MRC</a>) surged 8.9% to close at $9.87. The company recently released Q1 results.</li>
	<li>AtriCure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATRC#NASDAQ">ATRC</a>) gained 8.8% to close at $76.00 after the company reported that its EPi-Sense System was approved by the FDA for treatment of long-standing persistent afib patients.</li>
	<li>Facebook, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FB#NASDAQ">FB</a>) rose 7.3% to close at $329.51 after the company reported upbeat results for its first quarter on Wednesday. The company reported 1.88 billion daily active users, up 8% year-over-year, as well as 2.85 billion monthly active users, up 10% year-over-year.</li>
	<li>Cheesecake Factory Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAKE#NASDAQ">CAKE</a>) rose 7.1% to settle at $63.20 after reporting higher quarterly earnings.</li>
	<li>QUALCOMM Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) rose 4.5% to close at $142.68 after the company reported better-than-expected Q2 results and issued strong Q3 EPS guidance.</li>
</ul>

&nbsp;

<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>Adverum Biotechnologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADVM#NASDAQ">ADVM</a>) shares tumbled 62.3% to close at $3.83 on Thursday after the company announced a suspected unexpected serious adverse reaction of hypotony, which is clinically relevant decrease in ocular pressure, in its INFINITY clinical trial evaluating ADVM-022 gene therapy for the treatment of diabetic macular edema.</li>
	<li>Farmmi, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAMI#NASDAQ">FAMI</a>) fell 54.7% to close at $0.3580 after the company priced its $42.0 million upsized underwritten public offering of ordinary shares.</li>
	<li>Cara Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARA#NASDAQ">CARA</a>) dropped 45.4% to close at $14.07 after the company announced mixed topline results from its KARE Phase 2 dose-ranging clinical trial of oral Korsuva for the treatment of moderate-to-severe pruritus in mild-to-severe atopic dermatitis patients. The company said the study did not meet the primary endpoint of worst-itch NRS change from baseline at week 12 or secondary endpoint of 4-point responder analysis in the intent-to-treat patient population. However, the study achieved primary endpoint of worst-itch NRS change and secondary endpoint of 4-point responder analysis in pre-specified analyses of mild-to-moderate AD patients, comprising 64% of ITT population.</li>
	<li>Atomera Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATOM#NASDAQ">ATOM</a>) fell 24.8% to close at $16.68 after the company reported Q1 earnings results.</li>
	<li>Palisade Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PALI#NASDAQ">PALI</a>) fell 23.9% to close at $7.80.</li>
	<li>Brooklyn ImmunoTherapeutics, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTX#NYSE">BTX</a>) dipped 21.8% to close at $34.22. Brooklyn ImmunoTherapeutics acquired license for mRNA technology platform of Factor Bioscience Limited And Novellus Therapeutics Limited.</li>
	<li>Brightcove Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCOV#NASDAQ">BCOV</a>) dipped 20% to settle at $15.56 after the company issued Q2 EPS and sales guidance below estimates.</li>
	<li>Tiptree Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIPT#NASDAQ">TIPT</a>) fell 19.5% to close at $10.10 after the company reported it has decided to withdraw the registration statement relating to previously announced IPO by Fortegra due to &lsquo;prevailing market conditions and the high value.&rsquo;</li>
	<li>Impinj, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PI#NASDAQ">PI</a>) dropped 19.4% to settle at $46.81 after reporting a decline in quarterly earnings.</li>
	<li>Vyant Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VYNT#NASDAQ">VYNT</a>) fell 19.1% to close at $3.76 after climbing 16% on Wednesday. Vyant Bio, Ordaōs Bio and Cellaria, recently announced collaboration to &#39;design and qualify biomarker-specific small protein therapeutics.&#39;</li>
	<li>Selecta Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SELB#NASDAQ">SELB</a>) dipped 19% to close at $3.15. Based on an internal strategic review and prioritization of its portfolio, Asklepios BioPharmaceutical Inc (AskBio) has decided to give all rights of methylmalonic acidemia (MMA) to Selecta Biosciences.</li>
	<li>FormFactor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) fell 18.2% to close at $39.22 after the company reported worse-than-expected Q1 EPS results.</li>
	<li>Regional Health Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RHE#NYSE">RHE</a>) dropped 17.9% to close at $5.23.</li>
	<li>Galectin Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GALT#NASDAQ">GALT</a>) shares fell 16.9% to settle at $4.24 after jumping over 22% on Wednesday. The company recently announced neurosurgeon Dr. Ben Carson, Sr. joined the team as a special consultant to accelerate and enhance development of the company&#39;s galectin-3 inhibitor, belapectin.</li>
	<li>Cohu, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COHU#NASDAQ">COHU</a>) dipped 16.9% to close at $38.85 after reporting Q1 results.</li>
	<li>22nd Century Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NYSE">XXII</a>) fell 15.7% to settle at $4.74.</li>
	<li>Resolute Forest Products Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RFP#NYSE">RFP</a>) fell 15.4% to close at $13.17 after reporting preliminary Q1 results.</li>
	<li>Coeur Mining, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CDE#NYSE">CDE</a>) dropped 14.4% to settle at $8.23 after the company reported worse-than-expected Q1 EPS and sales results.</li>
	<li>Aurora Mobile Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JG#NASDAQ">JG</a>) fell 14.3% to close at $3.61.</li>
	<li>MicroVision, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) dipped 14.2% to close at $18.00.</li>
	<li>Aspen Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZPN#NASDAQ">AZPN</a>) fell 13.2% to settle at $132.64 after the company reported worse-than-expected Q3 EPS and sales results. The company also issued FY21 EPS and sales guidance below analyst estimates.</li>
	<li>Cree, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CREE#NASDAQ">CREE</a>) fell 12.6% to close at $98.53 after the company issued Q4 EPS guidance below analyst estimates. JP Morgan also downgraded the stock from Neutral to Underweight.</li>
	<li>Nemaura Medical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMRD#NASDAQ">NMRD</a>) fell 12.6% to close at $4.73.</li>
	<li>Smart Share Global Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EM#NASDAQ">EM</a>) dropped 12.5% to settle at $8.06.</li>
	<li>Ribbon Communications Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RBBN#NASDAQ">RBBN</a>) dipped 11.9% to close at $7.17 following weak quarterly sales.</li>
	<li>eBay Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>) fell 10% to settle at $56.07. eBay reported upbeat Q1 earnings, but issued weak earnings guidance for the current quarter.</li>
	<li>Lyft, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) fell 9.9% to close at $57.10 on reports the US Labor Secretary said most US gig workers should be classified as employees.</li>
	<li>Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) fell 9.4% to close at $11.26 after the company reported Q1 earnings results.</li>
	<li>ServiceNow, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) fell 9.4% to settle at $505.00 after the company reported Q1 earnings results.</li>
	<li>Peabody Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTU#NYSE">BTU</a>) dropped 9.3% to close at $3.89 following quarterly results.</li>
	<li>Hologic, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLX#NASDAQ">HOLX</a>) fell 8.5% to settle at $66.23 after the company reported worse-than-expected Q2 results and issued weak Q3 guidance.</li>
	<li>Teladoc Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TDOC#NASDAQ">TDOC</a>) fell 8.3% to close at $170.86 after reporting Q1 results.</li>
	<li>American Shared Hospital Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMS#NYSE">AMS</a>) dropped 8.3% to close at $2.44.</li>
	<li>Citrix Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTXS#NASDAQ">CTXS</a>) dropped 7.6% to close at $128.02 after the company reported worse-than-expected Q1 results.</li>
	<li>Tenaris S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TS#NYSE">TS</a>) fell 7.2% to close at $21.02 after the company reported Q1 results.</li>
</ul>

65 Biggest Movers From Yesterday

Piper Sandler analyst Harsh Kumar initiates coverage on SkyWater Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYT#NASDAQ">SKYT</a>) with a Overweight rating and announces Price Target of $25.

Price Target

Initiation

Analyst Ratings

Piper Sandler Initiates Coverage On SkyWater Technology with Overweight Rating, Announces Price Target of $25

Jefferies analyst Mark Lipacis initiates coverage on SkyWater Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYT#NASDAQ">SKYT</a>) with a Buy rating and announces Price Target of $27.

Jefferies Initiates Coverage On SkyWater Technology with Buy Rating, Announces Price Target of $27

&nbsp;

<h2>Upgrades</h2>

<ul>
	<li>B of A Securities upgraded the previous rating for Kosmos Energy Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KOS#NYSE">KOS</a>) from Neutral to Buy. In the first quarter, Kosmos Energy showed an EPS of $0.08, compared to $0.16 from the year-ago quarter. At the moment, the stock has a 52-week-high of $3.69 and a 52-week-low of $0.90. Kosmos Energy closed at $2.95 at the end of the last trading period.</li>
	<li>Argus Research upgraded the previous rating for Williams Companies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMB#NYSE">WMB</a>) from Hold to Buy. Williams Companies earned $0.35 in the first quarter, compared to $0.26 in the year-ago quarter. At the moment, the stock has a 52-week-high of $25.93 and a 52-week-low of $17.48. Williams Companies closed at $25.89 at the end of the last trading period.</li>
	<li>According to Wedbush, the prior rating for Children&#39;s Place Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLCE#NASDAQ">PLCE</a>) was changed from Neutral to Outperform. Children&#39;s Place earned $1.01 in the fourth quarter, compared to $1.85 in the year-ago quarter. At the moment, the stock has a 52-week-high of $85.59 and a 52-week-low of $17.78. Children&#39;s Place closed at $77.64 at the end of the last trading period.</li>
	<li>According to UBS, the prior rating for Credicorp Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAP#NYSE">BAP</a>) was changed from Neutral to Buy. Credicorp earned $0.70 in the first quarter, compared to $0.76 in the year-ago quarter. At the moment, the stock has a 52-week-high of $172.12 and a 52-week-low of $110.47. Credicorp closed at $145.83 at the end of the last trading period.</li>
	<li>B of A Securities upgraded the previous rating for Coca-Cola Europacific Partners PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCEP#NYSE">CCEP</a>) from Underperform to Buy. At the moment, the stock has a 52-week-high of $60.54 and a 52-week-low of $34.02. Coca-Cola Europacific closed at $60.28 at the end of the last trading period.</li>
	<li>According to B of A Securities, the prior rating for Cummins Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMI#NYSE">CMI</a>) was changed from Neutral to Buy. For the first quarter, Cummins had an EPS of $4.07, compared to year-ago quarter EPS of $3.18. The stock has a 52-week-high of $277.09 and a 52-week-low of $143.32. At the end of the last trading period, Cummins closed at $265.56.</li>
	<li>According to National Bank Of Canada, the prior rating for Pan American Silver Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAAS#NASDAQ">PAAS</a>) was changed from Sector Perform to Outperform. In the first quarter, Pan American Silver earned $0.18. At the moment, the stock has a 52-week-high of $40.11 and a 52-week-low of $21.36. Pan American Silver closed at $30.95 at the end of the last trading period.</li>
	<li>Deutsche Bank upgraded the previous rating for Texas Roadhouse Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXRH#NASDAQ">TXRH</a>) from Hold to Buy. In the first quarter, Texas Roadhouse showed an EPS of $0.91, compared to $0.24 from the year-ago quarter. The stock has a 52-week-high of $110.75 and a 52-week-low of $41.68. At the end of the last trading period, Texas Roadhouse closed at $98.55.</li>
	<li>According to Societe Generale, the prior rating for Occidental Petroleum Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>) was changed from Hold to Buy. For the first quarter, Occidental Petroleum had an EPS of $0.15, compared to year-ago quarter EPS of $0.52. The stock has a 52-week-high of $32.52 and a 52-week-low of $8.52. At the end of the last trading period, Occidental Petroleum closed at $25.07.</li>
	<li>According to Morgan Stanley, the prior rating for Trip.com Group Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>) was changed from Equal-Weight to Overweight. For the fourth quarter, Trip.com Group had an EPS of $0.27, compared to year-ago quarter EPS of $0.28. The stock has a 52-week-high of $45.19 and a 52-week-low of $22.35. At the end of the last trading period, Trip.com Group closed at $37.51.</li>
</ul>

<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings upgrades.</a>

&nbsp;

<h2>Downgrades</h2>

<ul>
	<li>According to Oppenheimer, the prior rating for Mirati Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRTX#NASDAQ">MRTX</a>) was changed from Outperform to Perform. For the first quarter, Mirati Therapeutics had an EPS of $2.67, compared to year-ago quarter EPS of $2.02. The current stock performance of Mirati Therapeutics shows a 52-week-high of $249.42 and a 52-week-low of $91.90. Moreover, at the end of the last trading period, the closing price was at $156.62.</li>
	<li>For Zions Bancorp NA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>), Baird downgraded the previous rating of Neutral to Underperform. Zions Bancorp earned $1.90 in the first quarter, compared to $0.04 in the year-ago quarter. The current stock performance of Zions Bancorp shows a 52-week-high of $60.44 and a 52-week-low of $25.07. Moreover, at the end of the last trading period, the closing price was at $60.20.</li>
</ul>

<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings downgrades.</a>

&nbsp;

<h2>Initiations</h2>

<ul>
	<li>William Blair initiated coverage on DoubleVerify Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DV#NYSE">DV</a>) with an Outperform rating. The stock has a 52-week-high of $38.28 and a 52-week-low of $28.52. At the end of the last trading period, DoubleVerify Hldgs closed at $30.86.</li>
	<li>With an Outperform rating, SMBC Nikko initiated coverage on UiPath Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>). The price target seems to have been set at $80.00 for UiPath. UiPath earned $0.04 in the second quarter, compared to $0.13 in the year-ago quarter. The stock has a 52-week-high of $83.40 and a 52-week-low of $61.50. At the end of the last trading period, UiPath closed at $70.48.</li>
	<li>With an Overweight rating, JP Morgan initiated coverage on Zymergen Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZY#NASDAQ">ZY</a>). The price target seems to have been set at $40.00 for Zymergen. The stock has a 52-week-high of $52.00 and a 52-week-low of $25.75. At the end of the last trading period, Zymergen closed at $31.92.</li>
	<li>B of A Securities initiated coverage on KnowBe4 Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNBE#NASDAQ">KNBE</a>) with a Buy rating. The price target for KnowBe4 is set to $24.00. The current stock performance of KnowBe4 shows a 52-week-high of $26.98 and a 52-week-low of $17.10. Moreover, at the end of the last trading period, the closing price was at $18.69.</li>
	<li>Citigroup initiated coverage on Apria Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APR#NASDAQ">APR</a>) with a Buy rating. The price target for Apria is set to $33.00. Apria earned $0.08 in the first quarter. The current stock performance of Apria shows a 52-week-high of $32.75 and a 52-week-low of $20.07. Moreover, at the end of the last trading period, the closing price was at $29.04.</li>
	<li>With an Overweight rating, JP Morgan initiated coverage on DoubleVerify Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DV#NYSE">DV</a>). The price target seems to have been set at $40.00 for DoubleVerify Hldgs. At the moment, the stock has a 52-week-high of $38.28 and a 52-week-low of $28.52. DoubleVerify Hldgs closed at $30.86 at the end of the last trading period.</li>
	<li>Truist Securities initiated coverage on KnowBe4 Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNBE#NASDAQ">KNBE</a>) with a Buy rating. The price target for KnowBe4 is set to $25.00. The stock has a 52-week-high of $26.98 and a 52-week-low of $17.10. At the end of the last trading period, KnowBe4 closed at $18.69.</li>
	<li>JP Morgan initiated coverage on NeuroPace Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NPCE#NASDAQ">NPCE</a>) with an Overweight rating. The price target for NeuroPace is set to $27.00. The stock has a 52-week-high of $27.38 and a 52-week-low of $18.24. At the end of the last trading period, NeuroPace closed at $20.91.</li>
	<li>Jefferies initiated coverage on SkyWater Technology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYT#NASDAQ">SKYT</a>) with a Buy rating. The price target for SkyWater Technology is set to $27.00. The current stock performance of SkyWater Technology shows a 52-week-high of $22.42 and a 52-week-low of $14.25. Moreover, at the end of the last trading period, the closing price was at $19.67.</li>
	<li>DA Davidson initiated coverage on UiPath Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Buy rating. The price target for UiPath is set to $85.00. For the second quarter, UiPath had an EPS of $0.04, compared to year-ago quarter EPS of $0.13. At the moment, the stock has a 52-week-high of $83.40 and a 52-week-low of $61.50. UiPath closed at $70.48 at the end of the last trading period.</li>
	<li>With an Outperform rating, SVB Leerink initiated coverage on Halozyme Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HALO#NASDAQ">HALO</a>). The price target seems to have been set at $56.00 for Halozyme Therapeutics. In the first quarter, Halozyme Therapeutics showed an EPS of $0.37, compared to $0.04 from the year-ago quarter. At the moment, the stock has a 52-week-high of $56.40 and a 52-week-low of $22.11. Halozyme Therapeutics closed at $43.03 at the end of the last trading period.</li>
	<li>With a Sector Perform rating, RBC Capital initiated coverage on UiPath Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>). The price target seems to have been set at $74.00 for UiPath. In the second quarter, UiPath showed an EPS of $0.04, compared to $0.13 from the year-ago quarter. The current stock performance of UiPath shows a 52-week-high of $83.40 and a 52-week-low of $61.50. Moreover, at the end of the last trading period, the closing price was at $70.48.</li>
	<li>With an Outperform rating, RBC Capital initiated coverage on DoubleVerify Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DV#NYSE">DV</a>). The price target seems to have been set at $37.00 for DoubleVerify Hldgs. At the moment, the stock has a 52-week-high of $38.28 and a 52-week-low of $28.52. DoubleVerify Hldgs closed at $30.86 at the end of the last trading period.</li>
	<li>With an Overweight rating, Morgan Stanley initiated coverage on NeuroPace Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NPCE#NASDAQ">NPCE</a>). The price target seems to have been set at $26.00 for NeuroPace. The stock has a 52-week-high of $27.38 and a 52-week-low of $18.24. At the end of the last trading period, NeuroPace closed at $20.91.</li>
	<li>Goldman Sachs initiated coverage on Zymergen Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZY#NASDAQ">ZY</a>) with a Buy rating. The price target for Zymergen is set to $55.00. The stock has a 52-week-high of $52.00 and a 52-week-low of $25.75. At the end of the last trading period, Zymergen closed at $31.92.</li>
	<li>Goldman Sachs initiated coverage on DoubleVerify Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DV#NYSE">DV</a>) with a Buy rating. The price target for DoubleVerify Hldgs is set to $47.00. At the moment, the stock has a 52-week-high of $38.28 and a 52-week-low of $28.52. DoubleVerify Hldgs closed at $30.86 at the end of the last trading period.</li>
	<li>Goldman Sachs initiated coverage on Opendoor Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPEN#NASDAQ">OPEN</a>) with a Neutral rating. The price target for Opendoor Technologies is set to $17.00. For the first quarter, Opendoor Technologies had an EPS of $0.04, compared to year-ago quarter EPS of $0.74. The current stock performance of Opendoor Technologies shows a 52-week-high of $39.24 and a 52-week-low of $13.44. Moreover, at the end of the last trading period, the closing price was at $15.12.</li>
	<li>Barclays initiated coverage on DoubleVerify Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DV#NYSE">DV</a>) with a Equal-Weight rating. The price target for DoubleVerify Hldgs is set to $36.00. At the moment, the stock has a 52-week-high of $38.28 and a 52-week-low of $28.52. DoubleVerify Hldgs closed at $30.86 at the end of the last trading period.</li>
	<li>Barclays initiated coverage on UiPath Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Equal-Weight rating. The price target for UiPath is set to $71.00. UiPath earned $0.04 in the second quarter, compared to $0.13 in the year-ago quarter. At the moment, the stock has a 52-week-high of $83.40 and a 52-week-low of $61.50. UiPath closed at $70.48 at the end of the last trading period.</li>
	<li>With an Outperform rating, National Bank Of Canada initiated coverage on The Lion Electric Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEV#NYSE">LEV</a>). The price target seems to have been set at $20.00 for Lion Electric. Lion Electric earned $0.15 in the first quarter, compared to $0.05 in the year-ago quarter. The current stock performance of Lion Electric shows a 52-week-high of $20.20 and a 52-week-low of $13.87. Moreover, at the end of the last trading period, the closing price was at $15.04.</li>
	<li>Piper Sandler initiated coverage on KnowBe4 Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNBE#NASDAQ">KNBE</a>) with an Overweight rating. The price target for KnowBe4 is set to $24.00. The current stock performance of KnowBe4 shows a 52-week-high of $26.98 and a 52-week-low of $17.10. Moreover, at the end of the last trading period, the closing price was at $18.69.</li>
	<li>With an Overweight rating, Piper Sandler initiated coverage on SkyWater Technology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYT#NASDAQ">SKYT</a>). The price target seems to have been set at $25.00 for SkyWater Technology. At the moment, the stock has a 52-week-high of $22.42 and a 52-week-low of $14.25. SkyWater Technology closed at $19.67 at the end of the last trading period.</li>
</ul>

<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings initiations.</a>

Upgrades

Downgrades

Intraday Update

Benzinga's Top Ratings Upgrades, Downgrades For May 17, 2021

SkyWater Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYT#NASDAQ">SKYT</a>) reported $48.10 million in sales this quarter. This is a 30.35 percent increase over sales of $36.90 million the same period last year.

Earnings

SkyWater Technology Q1 Sales $48.10M Up From $36.90M YoY

<ul>
	<li>Program includes a pre-designed carrier chip and automated open source design flow from Efabless</li>
	<li>SkyWater&#39;s open source SKY130 process is the first node to be used&nbsp;to fabricate chips for the program</li>
	<li>Initiative removes access barriers by significantly reducing cost and the need for deep semiconductor experience to design chips</li>
</ul>

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.efabless.com%2F&amp;esheet=52432851&amp;newsitemid=20210520005351&amp;lan=en-US&amp;anchor=Efabless&amp;index=1&amp;md5=f705142fb4014e9c379c82407445d707">Efabless</a>, a community chip creation platform, today announced the launch of its new chipIgnite program to bring chip design and fabrication to the masses and a collaboration with&nbsp;<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.skywatertechnology.com%2F&amp;esheet=52432851&amp;newsitemid=20210520005351&amp;lan=en-US&amp;anchor=SkyWater+Technology&amp;index=2&amp;md5=53b4bafe493772ee824b086ce6ea03f8">SkyWater Technology</a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYT#NASDAQ">SKYT</a>) for the first node supported in the program. The chipIgnite program expands upon the SKY130-based open source chip manufacturing program sponsored by Google and supports private commercial designs that include non-open source IP. This initiative represents another step forward in the industry to broaden access to chip design by giving people the ability to more easily create and fabricate chips.

The chipIgnite program offers unique value to the designer which includes not only low-cost manufacturing, but also a development board and firmware stack to simplify design validation and test. All projects created as part of the chipIgnite program will utilize a full chip reference design template that implements the physical IO for the chip as well as provides a common management area to support test and evaluation of the user&#39;s design. The program also includes an optional automated open source design flow for implementing projects that enables users to generate layouts for their digital projects from RTL. The chipIgnite program will provide users a guaranteed reservation to ensure their project is included.

SkyWater&#39;s open source 130 nm CMOS platform will be used to fabricate chips for the chipIgnite program. The automotive-grade mixed-signal platform is well suited for IoT and edge computing as it is in a sweet spot for enabling a combination of both digital and analog circuit performance with embedded non-volatile memory for a wide range of SoC architectures. The program provides users 10 mm2&nbsp;of total project area with fabrication for projects using the SkyWater Open Source PDK.

The chipIgnite program builds on an active community of 1500+ users for the Open PDK initiative where new designers can get support and access to resources through community messaging platforms such as Slack. In addition to using freely-available design flows based on open source EDA tools, designers can also employ proprietary design tools for creating their designs, allowing them to address design requirements not supported by open source tools.

The program is a good fit for users who want to create an initial prototype or proof-of-concept for an IP block or full SoC. The starting price of&nbsp;$9750&nbsp;per project includes 100 QFN or 300 WCSP packaged parts and five evaluation boards. The chipIgnite shuttles also support users who are distributing initial boards or launching a pilot for their product. An option for 1000 WCSP parts at&nbsp;$20&nbsp;each is available that enables the service to be used for early product builds.

The first manufacturing run in the chipIgnite program is optimized for university digital and mixed-signal chip design courses with a submission deadline for tapeout of June 18, 2021. The delivery of parts and assembled boards is planned for early October.

The first shuttle in the chipIgnite program will support fabrication of student projects as part of the EE272B course in the Electrical Engineering department at Stanford University for senior undergraduate and graduate students.

The new program also has industry support from organizations including QuickLogic and the CHIPS Alliance.

&quot;QuickLogic joins Efabless and SkyWater in fully supporting open source initiatives,&quot; said Brian Faith, CEO of QuickLogic. &quot;The new chipIgnite program is a great way for innovators to create customized devices quickly and cost effectively.&quot;

&quot;CHIPS Alliance is a major champion of open source hardware design and associated design automation tools. I am excited to see the chipIgnite program offered by Efabless to include many different collaborative IP developers to prove new ideas. The platform alleviates the barriers to entry into chip design and allows for ready exploration of many concepts,&quot; said Rob Mains, general manager of CHIPS Alliance.

Contracts

SkyWater Says Efabless Launches ChipIgnite With Co To Bring Chip Creation To Masses

<h3>Gainers</h3>

<ul>
	<li>Big Rock Partners Acquisition Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRPA#NASDAQ">BRPA</a>) shares jumped 88% to settle at $36.08 on Thursday.</li>
	<li>Urban One, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UONE#NASDAQ">UONE</a>) gained 59.1% to close at $9.56. Urban One likely benefited from fast-food giant McDonald&rsquo;s announcement that it will increase its national advertising spending in Black, Hispanic, Asian, women and LGBTQ-owned media platforms from 4% to 10% between 2021 and 2024.</li>
	<li>Newegg Commerce Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEGG#NASDAQ">NEGG</a>) shares surged 43.6% to close at $13.24 on Thursday.</li>
	<li>Sensei Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNSE#NASDAQ">SNSE</a>) gained 30.1% to close at $12.66. Sensei Biotherapeutics revealed new data from the ongoing Phase 1/2 clinical trial of SNS-301 in patients with advanced squamous cell carcinoma of the head and neck (SCCHN), in combination with pembrolizumab.</li>
	<li>PDS Biotechnology Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDSB#NASDAQ">PDSB</a>) jumped 26.7% to close at $7.27 after the company announced the publication of an abstract by the American Society of Clinical Oncology summarizing interim data from the National Cancer Institute (NCI)-led Phase 2 trial evaluating a combination of PDS0101, M9241, and bintrafusp alfa in patients with HPV 16+ relapsed or refractory advanced cancer.</li>
	<li>Vera Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERA#NASDAQ">VERA</a>) climbed 26.1% to close at $19.36. Vera Therapeutics, last week, priced its 4.35 million share IPO at $11 per share, well below its targeted range of $14 to $16, raising $47.58 million in gross proceeds.</li>
	<li>SkyWater Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYT#NASDAQ">SKYT</a>) gained 26% to settle at $26.40 after the company said Efabless announced the launch of ChipIgnite with the company to bring chip creation to masses.</li>
	<li>Oxbridge Re Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXBR#NASDAQ">OXBR</a>) surged 24.6% to close at $2.63.</li>
	<li>LM Funding America, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMFA#NASDAQ">LMFA</a>) gained 22.3% to settle at $4.71 after McDonalds announced investment in diverse media. The stock has been seen as a play on diverse media.</li>
	<li>BBQ Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBQ#NASDAQ">BBQ</a>) jumped 20.4% to close at $14.75 after the company reported a rise in quarterly sales.</li>
	<li>Oatly Group AB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTLY#NASDAQ">OTLY</a>) gained 18.8% to settle at $20.20 after announcing an initial public offering on of 84.4 million American Depositary Shares priced at $17 a share, on the high end of expectations.</li>
	<li>Nam Tai Property Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTP#NYSE">NTP</a>) jumped 18.7% to close at $23.84.</li>
	<li>Progenity, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROG#NASDAQ">PROG</a>) gained 18.3% to settle at $2.65.</li>
	<li>Gores Holdings VI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GHVI#NASDAQ">GHVI</a>) surged 18.1% to close at $13.11.</li>
	<li>LifeMD, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFMD#NASDAQ">LFMD</a>) gained 17.4% to close at $12.13.</li>
	<li>Euro Tech Holdings Company Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLWT#NASDAQ">CLWT</a>) jumped 17.4% to close at $4.25.</li>
	<li>PyroGenesis Canada Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYR#NASDAQ">PYR</a>) gained 16.8% to close at $5.07. The company recently released Q1 results.</li>
	<li>Genetron Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTH#NASDAQ">GTH</a>) climbed 16.7% to settle at $22.65 after the company reported a strategic partnership with JD Health to create innovative solutions for full-cycle cancer management.</li>
	<li>Intrusion Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) gained 16% to settle at $15.08.</li>
	<li>Moxian, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOXC#NASDAQ">MOXC</a>) rose 15.9% to close at $14.84.</li>
	<li>Immutep Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMMP#NASDAQ">IMMP</a>) jumped 15.8% to close at $4.77 after the company announced the publication of TACTI-002 and INSIGHT-004 abstracts for ASCO 2021 Annual Meeting.</li>
	<li>Lightspeed POS Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LSPD#NYSE">LSPD</a>) surged 15.7% to settle at $66.45 after reporting Q4 results.</li>
	<li>Decibel Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBTX#NASDAQ">DBTX</a>) gained 15.7% to close at $8.71.</li>
	<li>Advanced Emissions Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADES#NASDAQ">ADES</a>) rose 14.9% to settle at $6.15.</li>
	<li>SG Blocks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) shares jumped 14.9% to close at $3.55 after the company issued strong sales guidance for the first quarter.</li>
	<li>Iovance Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>) surged 14.8% to close at $18.75. Iovance Biotherapeutics recently provided a regulatory update for lifileucel potency assays. Following the update, the company CEO resigned.</li>
	<li>Youdao, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAO#NYSE">DAO</a>) shares surged 14.8% to close at $25.72 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and announced a price target of $30 per share.</li>
	<li>Precipio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPO#NASDAQ">PRPO</a>) rose 14.8% to close at $4.74. Precipio recently announced it launched a new, four-hour Acute Myeloid Leukemia HemeScreen panel to specifically determine the genetics of this aggressive, acute form of leukemia.</li>
	<li>Virgin Galactic Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPCE#NYSE">SPCE</a>) surged 14.7% to close at $19.81 on news out from the company for its planned timeline of taking passengers to space.</li>
	<li>InnSuites Hospitality Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHT#NYSE">IHT</a>) shares gained 12.8% to settle at $5.92 after dropping 11% on Wednesday. The company recently reported 2021 sales of $4.20 million versus $6.57 million year over year.</li>
	<li>DarioHealth Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRIO#NASDAQ">DRIO</a>) gained 12.4% to settle at $17.54. DarioHealth recently reported a Q1 net loss of $15 million and agreed to acquire PsyInnovations Inc (dba wayForward), a behavioral health digital platform, for $30 million.</li>
	<li>VistaGen Therapeutics, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTGN#NASDAQ">VTGN</a>) shares gained 12.2% to close at $2.58. Baird initiated coverage on the stock with an Outperform rating and a $9 price target.</li>
	<li>F-star Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSTX#NASDAQ">FSTX</a>) rose 12% to close at $7.76. HC Wainwright &amp; Co. recently initiated coverage on the stock with a Buy rating and a price target of $35 per share.</li>
	<li>PolarityTE, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTE#NASDAQ">PTE</a>) rose 11.3% to close at $1.09 after a Form4 filing showed insider Peter A Cohen bought 265,000 shares of common stock at $0.98 per share for a total cost of $259,382.</li>
	<li>Summit Wireless Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WISA#NASDAQ">WISA</a>) rose 7.6% to close at $4.38. The company, last week, released quarterly results.</li>
	<li>Super League Gaming, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLGG#NASDAQ">SLGG</a>) gained 7.1% to close at $4.67. Super League Gaming recently reported a Q1 loss of $0.21 per share.</li>
	<li>Adaptimmune Therapeutics plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADAP#NASDAQ">ADAP</a>)shares rose 4.5% to settle at $5.12 after the company revealed initial data from its Phase 2 SPEARHEAD-1 trial evaluating afamitresgene autoleucel (afami-cel, formerly ADP-A2M4).</li>
</ul>

&nbsp;

 
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>Black Diamond Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDTX#NASDAQ">BDTX</a>) shares tumbled 37.3% to close at $13.93 on Thursday after the company reported initial data from the Phase 1 dose-escalation portion of the Phase 1/2 MasterKey-01 trial evaluating BDTX-189 in patients with advanced solid tumors.</li>
	<li>Onconova Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONTX#NASDAQ">ONTX</a>) dipped 21.1% to close at $0.73 after the company announced a 1-for-15 reverse stock split.</li>
	<li>Alpine Immune Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALPN#NASDAQ">ALPN</a>) dropped 16.6% to settle at $12.54.</li>
	<li>Merus N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRUS#NASDAQ">MRUS</a>) shares fell 15.6% to close at $21.29. Merus reported publication of abstract on Zenocutuzumab in NRG1-fusion (NRG1+) cancers at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting.</li>
	<li>Lordstown Motors Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIDE#NASDAQ">RIDE</a>) fell 15.3% to close at $9.70 after Wolfe Research downgraded the stock from Peer Perform to Underperform and lowered its price target from $18 to $1.</li>
	<li>Lixte Biotechnology Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIXT#NASDAQ">LIXT</a>) dipped 13% to settle at $2.74.</li>
	<li>FutureFuel Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FF#NYSE">FF</a>) shares fell 12.4% to close at $11.78. FutureFuel, earlier during the month, reported Q1 results.</li>
	<li>HOOKIPA Pharma Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOK#NASDAQ">HOOK</a>) fell 12.3% to close at $16.69. HOOKIPA will present Phase 1 safety, tolerability and preliminary anti-tumor activity data on Hb-201 and Hb-202 for the treatment of advanced Hpv16+ cancers at the ASCO.</li>
	<li>Renewable Energy Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGI#NASDAQ">REGI</a>) dropped 11.8% to settle at $57.46.</li>
	<li>Omeros Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMER#NASDAQ">OMER</a>) tumbled 10.8% to close at $15.14 after the company revealed that the FDA needs additional time to review narsoplimab marketing application for hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA).</li>
	<li>Fossil Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOSL#NASDAQ">FOSL</a>) fell 10.6% to settle at $11.85.</li>
	<li>Harrow Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HROW#NASDAQ">HROW</a>) dipped 10.3% to close at $9.93. The company, last week, reported Q1 results.</li>
	<li>Voyager Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VYGR#NASDAQ">VYGR</a>) dropped 10.2% to settle at $3.94. Voyager Therapeutics CEO and President Andre Turenne will step down as the beleaguered company announced it would move focus to early, discovery-stage efforts.</li>
	<li>Kohl&#39;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) fell 10.2% to settle at $54.12 despite the company better-than-expected Q1 results and raised FY21 outlook.</li>
	<li>PaySign, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYS#NASDAQ">PAYS</a>) dropped 10.1% to close at $3.40.</li>
	<li>21Vianet Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNET#NASDAQ">VNET</a>) tumbled 9.6% to settle at $22.48.</li>
	<li>KnowBe4, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNBE#NASDAQ">KNBE</a>) dropped 9.4% to close at $17.65 following Q1 results.</li>
	<li>Triumph Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGI#NYSE">TGI</a>) fell 8% to close at $15.13 following Q4 results.</li>
	<li>Aerpio Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARPO#NASDAQ">ARPO</a>) fell 7.7% to settle at $2.05. The company issued an update on Aadi Bioscience presentation at the ASCO 2021 virtual meeting.</li>
	<li>Abercrombie &amp; Fitch Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANF#NYSE">ANF</a>) fell 7.7% to close at $37.41.</li>
	<li>Rice Acquisition Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RICE#NASDAQ">RICE</a>) dropped 7.3% to settle at $14.74.</li>
	<li>Ralph Lauren Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RL#NYSE">RL</a>) fell 7% to close at $121.87. Ralph Lauren swung to a profit in the fourth quarter.</li>
	<li>Wunong Net Technology Company Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WNW#NASDAQ">WNW</a>) fell 6.4% to close at $6.98 after the company received notice of non-compliance with Nasdaq related to delayed filing of Form 20-F for FY20 period.</li>
</ul>

60 Biggest Movers From Yesterday

<h3>Gainers</h3>

<ul>
	<li>SemiLEDs Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEDS#NASDAQ">LEDS</a>) shares surged 28.4% to $10.17 following reports indicating equipment billings increased 50% in April compared to the prior year&#39;s period.</li>
	<li>Friedman Industries, Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRD#NYSE">FRD</a>) gained 23.9% to $13.40. Friedman Industries said it sees Q4 earnings of $1.37 to $1.52 per share.</li>
	<li>Provention Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRVB#NASDAQ">PRVB</a>) shares jumped 22.4% to $9.77. FDA&#39;s Endocrinologic and Metabolic Drugs Advisory Committee will meet on Thursday to discuss Provention Bio&rsquo;s BLA for teplizumab intravenous infusion, for the delay or prevention of clinical type 1 diabetes mellitus in at-risk individuals. The FDA will release a briefing document prepared by FDA staffers that will provide background and other information for deliberation by the FDA panel.</li>
	<li>uCloudlink Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCL#NASDAQ">UCL</a>) surged 19.4% to $13.07.</li>
	<li>The Joint Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JYNT#NASDAQ">JYNT</a>) gained 19% to $69.22 after it was announced the company will join the S&amp;P SmallCap 600.</li>
	<li>U.S. Well Services, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USWS#NASDAQ">USWS</a>) surged 18.9% to $1.1382 after the company announced the move towards full electrification of its portfolio.</li>
	<li>Taiwan Liposome Company, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLC#NASDAQ">TLC</a>) shares gained 18.6% to $5.87 after India&#39;s Central Drugs Standard Control Organization approved the company&rsquo;s marketing application for Amphotericin B Liposome for 50mg Injection for immediate import to aid in the country&#39;s emergency of acute liposomal amphotericin B shortage..</li>
	<li>Rain Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAIN#NASDAQ">RAIN</a>) gained 17% to $20.29 after the company reported Q1 results.</li>
	<li>New Oriental Education &amp; Technology Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDU#NYSE">EDU</a>) shares rose 16.3% to $10.55 after dropping over 18% on Monday.</li>
	<li>RYB Education, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYB#NYSE">RYB</a>) gained 15.2% to $4.03.</li>
	<li>Luokung Technology Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKCO#NASDAQ">LKCO</a>) rose 15.1% to $1.37.</li>
	<li>Comstock Mining Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LODE#NASDAQ">LODE</a>) gained 14.7% to $4.0427. The company recently released Q1 results.</li>
	<li>UP Fintech Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIGR#NASDAQ">TIGR</a>) shares rose 13.2% to $19.40 following Q1 results.</li>
	<li>Opera Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPRA#NASDAQ">OPRA</a>) jumped 12.7% to $11.81. Opera, last week, received Nasdaq notification of non-compliance with listing rule 5250(c)(1).</li>
	<li>TAL Education Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAL#NYSE">TAL</a>) shares rose 12.3% to $39.94 after dropping over 17% on Monday.</li>
	<li>Rodgers Silicon Valley Acquisition Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSVA#NASDAQ">RSVA</a>) surged 11.9% to $15.18.</li>
	<li>LifeMD, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFMD#NASDAQ">LFMD</a>) climbed 10.6% to $12.45.</li>
	<li>Ashford Hospitality Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHT#NYSE">AHT</a>) climbed 10.3% to $3.4214.</li>
	<li>PainReform Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRFX#NASDAQ">PRFX</a>) gained 9.7% to $2.8192.</li>
	<li>LSI Industries Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYTS#NASDAQ">LYTS</a>) gained 9.5% to $9.01 after the company announced the acquisition of JSI Store Fixtures from RFE Investment Partners for a cash purchase price of $90 million.</li>
	<li>Ault Global Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPW#NYSE">DPW</a>) rose 9.1% to $2.5625 following Q1 results. The company reported a rise in quarterly sales.</li>
	<li>TrueCar, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUE#NASDAQ">TRUE</a>) gained 8.2% to $5.41. TrueCar said it expects total new vehicle sales rising 36% for May.</li>
	<li>Hydrofarm Holdings Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYFM#NASDAQ">HYFM</a>) shares rose 7.5% to $57.77 after the company announced it entered into an agreement to acquire House &amp; Garden for $125 million.</li>
	<li>Nordson Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDSN#NASDAQ">NDSN</a>) rose 6.6% to $215.83 after the company reported better-than-expected results for its second quarter. The company said it expects FY21 earnings of $7.20 to $7.50 per share.</li>
	<li>GSX Techedu Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOTU#NYSE">GOTU</a>) shares rose 5.1% to $20.03. GSX Techedu is expected to report Q1 results on May 26.</li>
	<li>So-Young International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SY#NASDAQ">SY</a>) rose 5% to $9.58. The company recently reported Q1 results.</li>
	<li>Scholar Rock Holding Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRRK#NASDAQ">SRRK</a>) rose 4.2% to $27.88 after the company announced it received FDA Fast Track designation for apitegromab for the treatment of patients with spinal muscular atrophy.</li>
</ul>

 
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>Petros Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTPI#NASDAQ">PTPI</a>) fell 16.3% to $3.44 after climbing 38% on Monday.</li>
	<li>Vimeo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMEO#NASDAQ">VMEO</a>) shares dropped 15% to $44.26.</li>
	<li>Lordstown Motors Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIDE#NASDAQ">RIDE</a>) fell 14.1% to $8.31 after the company reported a wider loss for the first quarter.</li>
	<li>China Green Agriculture, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CGA#NYSE">CGA</a>) dipped 13.8% to $9.15 after dropping 32% on Monday.</li>
	<li>SkyWater Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYT#NASDAQ">SKYT</a>) tumbled 12.3% to $25.70. The company recently said Efabless announced the launch of ChipIgnite with the company to bring chip creation to masses.</li>
	<li>Achieve Life Sciences Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHV#NASDAQ">ACHV</a>) fell 11.7% to $7.63 after the company announced a proposed underwritten public offering.</li>
	<li>Dycom Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DY#NYSE">DY</a>) dipped 11.3% to $73.67 after the company reported worse-than-expected Q1 results.</li>
	<li>89bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETNB#NASDAQ">ETNB</a>) fell 11.2% to $17.23. Raymond James downgraded 89bio from Strong Buy to Outperform and lowered the price target from $65 to $35.</li>
	<li>Viking Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>) declined 10.5% to $5.26. Raymond James downgraded Viking Therapeutics from Strong Buy to Outperform and lowered the price target from $27 to $12.</li>
	<li>Safe Bulkers, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SB#NYSE">SB</a>) dropped 9.9% to $3.9699.</li>
	<li>HyreCar Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYRE#NASDAQ">HYRE</a>) tumbled 9.7% to $15.70. HyreCar recently announced that it has renewed its Automobile Liability Insurance Program with Apollo 1969 of Lloyd&rsquo;s until 2023 at current rates.</li>
	<li>Soc Telemed Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLMD#NASDAQ">TLMD</a>) fell 9.6% to $6.78 after the company announced a proposed public offering of 8 million shares of Class A common stock.</li>
	<li>Aptorum Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APM#NASDAQ">APM</a>) dropped 9.3% to $2.54. The company recently highlighted interim Phase I clinical trial progress for ALS-4 and Pre-IND progress for SACT-1.</li>
	<li>Adamis Pharmaceuticals Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADMP#NASDAQ">ADMP</a>) fell 9.1% to $0.6759. Adamis Pharmaceuticals recently announced that it resubmitted its ZIMHI new drug application to the FDA for the treatment of Opoid overdose.</li>
	<li>Citi Trends, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTRN#NASDAQ">CTRN</a>) fell 8% to $82.75 despite the company reported better-than-expected Q1 results.</li>
</ul>

42 Stocks Moving In Tuesday's Mid-Day Session

<h3>Gainers</h3>

<ul>
	<li>Flanigan&#39;s Enterprises, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BDL#NYSE">BDL</a>) shares surged 40.6% to close at $34.90 on Tuesday after the company reported results for the 13 weeks and the 26 weeks ended April 3, 2021.</li>
	<li>Moxian, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOXC#NASDAQ">MOXC</a>) gained 30.3% to close at $17.96.</li>
	<li>Taiwan Liposome Company, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLC#NASDAQ">TLC</a>) shares jumped 28.7% to settle at $6.37 after India&#39;s Central Drugs Standard Control Organization approved the company&rsquo;s marketing application for Amphotericin B Liposome for 50mg Injection for immediate import to aid in the country&#39;s emergency of acute liposomal amphotericin B shortage..</li>
	<li>Protagenic Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) gained 28.3% to settle at $2.72.</li>
	<li>Provention Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRVB#NASDAQ">PRVB</a>) shares surged 26.8% to close at $10.12 on Tuesday. FDA&#39;s Endocrinologic and Metabolic Drugs Advisory Committee will meet on Thursday to discuss Provention Bio&rsquo;s BLA for teplizumab intravenous infusion, for the delay or prevention of clinical type 1 diabetes mellitus in at-risk individuals. The FDA will release a briefing document prepared by FDA staffers that will provide background and other information for deliberation by the FDA panel.</li>
	<li>Reading International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDIB#NASDAQ">RDIB</a>) gained 26.8% to settle at $27.73.</li>
	<li>Friedman Industries, Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRD#NYSE">FRD</a>) shares jumped 24.4% to settle at $13.45 on Tuesday. Friedman Industries said it sees Q4 earnings of $1.37 to $1.52 per share.</li>
	<li>Koss Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOSS#NASDAQ">KOSS</a>) gained 22.9% to settle at $20.78 amid continued speculative retail trading in the name.</li>
	<li>New Oriental Education &amp; Technology Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDU#NYSE">EDU</a>) shares jumped 20.8% to close at $10.96 after dropping over 18% on Monday.</li>
	<li>SemiLEDs Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEDS#NASDAQ">LEDS</a>) shares gained 20% to close at $9.50 on Tuesday following reports indicating equipment billings increased 50% in April compared to the prior year&#39;s period.</li>
	<li>AMC Entertainment Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) rose 20% to settle at $16.41 mid continued speculative retail trading in the name.</li>
	<li>TAL Education Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAL#NYSE">TAL</a>) shares jumped 18.5% to settle at $42.14 after dropping over 17% on Monday.</li>
	<li>The Joint Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JYNT#NASDAQ">JYNT</a>) climbed 17.8% to close at $68.50 after it was announced the company will join the S&amp;P SmallCap 600.</li>
	<li>GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) gained 16.3% to settle at $209.43. GameStop has quietly confirmed it is building a new non-fungible token (NFT) platform based on the Ethereum (ETH) blockchain platform.</li>
	<li>Rezolute, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RZLT#NASDAQ">RZLT</a>) rose 16.3% to close at $7.44 after HC Wainwright &amp; Co initiated coverage on the stock with a Buy rating and a $21 price target.</li>
	<li>UP Fintech Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIGR#NASDAQ">TIGR</a>) shares jumped 14.9% to close at $19.70 following Q1 results.</li>
	<li>U.S. Well Services, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USWS#NASDAQ">USWS</a>) gained 14.9% to close at $1.10 after the company announced the move towards full electrification of its portfolio.</li>
	<li>Viant Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSP#NASDAQ">DSP</a>) rose 13.7% to settle at $25.86.</li>
	<li>New Pacific Metals Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEWP#NYSE">NEWP</a>) surged 12.8% to close at $6.26.</li>
	<li>Ashford Hospitality Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHT#NYSE">AHT</a>) gained 12.3% to close at $3.48.</li>
	<li>RYB Education, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYB#NYSE">RYB</a>) rose 12% to close at $3.92.</li>
	<li>Luokung Technology Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKCO#NASDAQ">LKCO</a>) climbed 11.8% to close at $1.33.</li>
	<li>Ault Global Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPW#NYSE">DPW</a>) rose 10.6% to close at $2.60 following Q1 results. The company reported a rise in quarterly sales.</li>
	<li>TrueCar, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUE#NASDAQ">TRUE</a>) surged 10.4% to settle at $5.52. TrueCar said it expects total new vehicle sales rising 36% for May.</li>
	<li>Opera Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPRA#NASDAQ">OPRA</a>) surged 9.9% to close at $11.52. Opera, last week, received Nasdaq notification of non-compliance with listing rule 5250(c)(1).</li>
	<li>Comstock Mining Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LODE#NASDAQ">LODE</a>) rose 9.4% to settle at $3.85. The company recently released Q1 results.</li>
	<li>Rain Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAIN#NASDAQ">RAIN</a>) rose 9.4% to close at $18.98 after the company reported Q1 results.</li>
	<li>Hydrofarm Holdings Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYFM#NASDAQ">HYFM</a>) shares gained 9.2% to close at $58.65 after the company announced it entered into an agreement to acquire House &amp; Garden for $125 million.</li>
	<li>LSI Industries Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYTS#NASDAQ">LYTS</a>) climbed 9.1% to settle at $8.98 after the company announced the acquisition of JSI Store Fixtures from RFE Investment Partners for a cash purchase price of $90 million.</li>
	<li>PainReform Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRFX#NASDAQ">PRFX</a>) rose 8.2% to close at $2.78.</li>
	<li>Rodgers Silicon Valley Acquisition Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSVA#NASDAQ">RSVA</a>) gained 8% to close at $14.64.</li>
	<li>Nordson Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDSN#NASDAQ">NDSN</a>) gained 7.1% to close at $216.83 after the company reported better-than-expected results for its second quarter. The company said it expects FY21 earnings of $7.20 to $7.50 per share.</li>
</ul>

 
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>Petros Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTPI#NASDAQ">PTPI</a>) shares dropped 17% to close at $3.41 on Tuesday after climbing 38% on Monday.</li>
	<li>Obalon Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OBLN#NASDAQ">OBLN</a>) tumbled 16.9% to settle at $3.24.</li>
	<li>HyreCar Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYRE#NASDAQ">HYRE</a>) fell 16% to close at $14.60. HyreCar recently announced that it has renewed its Automobile Liability Insurance Program with Apollo 1969 of Lloyd&rsquo;s until 2023 at current rates.</li>
	<li>Gracell Biotechnologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRCL#NASDAQ">GRCL</a>) dropped 15.8% to close at $15.51.</li>
	<li>Achieve Life Sciences Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHV#NASDAQ">ACHV</a>) fell 15.4% to close at $7.31 after the company announced a proposed underwritten public offering.</li>
	<li>Dycom Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DY#NYSE">DY</a>) fell 15% to close at $70.51 after the company reported worse-than-expected Q1 results.</li>
	<li>Newegg Commerce, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEGG#NASDAQ">NEGG</a>) dropped 14.8% to settle at $10.63. Quadpay, a Zip Company, announced a partnership with Newegg Inc.</li>
	<li>Brooklyn ImmunoTherapeutics, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTX#NYSE">BTX</a>) declined 13.6% to close at $14.66. The company recently said it strengthened investment in licensed mRNA technology platform with $20 million.</li>
	<li>Annovis Bio, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANVS#NYSE">ANVS</a>) dropped 13.1% to settle at $48.80. Annovis Bio recently priced 1 million share public offering at $50 per share.</li>
	<li>Trinity Biotech plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIB#NASDAQ">TRIB</a>) fell 13% to close at $3.22 after the company reported Q1 earnings results.</li>
	<li>Vimeo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMEO#NASDAQ">VMEO</a>) shares fell 12.9% to close at $45.39.</li>
	<li>Burcon NutraScience Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRCN#NASDAQ">BRCN</a>) dropped 12.7% to settle at $3.5797.</li>
	<li>Safe Bulkers, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SB#NYSE">SB</a>) dipped 12.2% to settle at $3.87.</li>
	<li>SkyWater Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYT#NASDAQ">SKYT</a>) fell 12% to settle at $25.78. The company recently said Efabless announced the launch of ChipIgnite with the company to bring chip creation to masses.</li>
	<li>Viking Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>) declined 11.2% to close at $5.21. Raymond James downgraded Viking Therapeutics from Strong Buy to Outperform and lowered the price target from $27 to $12.</li>
	<li>89bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETNB#NASDAQ">ETNB</a>) fell 10.2% to settle at $17.42. Raymond James downgraded 89bio from Strong Buy to Outperform and lowered the price target from $65 to $35.</li>
	<li>Adamis Pharmaceuticals Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADMP#NASDAQ">ADMP</a>) dropped 9.4% to settle at $0.6740. Adamis Pharmaceuticals recently announced that it resubmitted its ZIMHI new drug application to the FDA for the treatment of Opoid overdose.</li>
	<li>Soc Telemed Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLMD#NASDAQ">TLMD</a>) fell 8.7% to close at $6.85 after the company announced a proposed public offering of 8 million shares of Class A common stock.</li>
	<li>China Green Agriculture, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CGA#NYSE">CGA</a>) fell 8.4% to close at $9.74 after dropping 32% on Monday.</li>
	<li>Lordstown Motors Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIDE#NASDAQ">RIDE</a>) fell 7.5% to settle at $8.95 after the company reported a wider loss for the first quarter.</li>
	<li>Citi Trends, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTRN#NASDAQ">CTRN</a>) fell 7.3% to close at $83.39 despite the company reported better-than-expected Q1 results.</li>
	<li>Aptorum Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APM#NASDAQ">APM</a>) fell 6.4% to close at $2.62. The company recently highlighted interim Phase I clinical trial progress for ALS-4 and Pre-IND progress for SACT-1.</li>
</ul>

54 Biggest Movers From Yesterday

<h3>Gainers</h3><ul>
	<li>Aethlon Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEMD#NASDAQ">AEMD</a>) shares jumped 371% to $10.41 in reaction to Zacks Article &#39;AEMD: First Ever In Vivo Removal Of COVID Virus From Bloodstream Of An Infected Patient.&#39; The company recently announced the positive results from using its Hemopurifier in treating two critically ill COVID-19 patients, which is available under the FDA emergency use authorization (EUA).</li>
	<li>Antelope Enterprise Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHL#NASDAQ">AEHL</a>) shares climbed 37.7% to $5.50 on abnormally-high volume.</li>
	<li>The GEO Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) gained 37.4% to $8.74 amid continued retail investor interest in high-short interest stocks.</li>
	<li>SPI Energy Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPI#NASDAQ">SPI</a>) jumped 31.1% to $8.17. SPI Energy&rsquo;s subsidiary Solar4America recently launched a new cloud-based online monitoring and maintenance system, Apollo, for solar systems, energy storage, and smart energy management.</li>
	<li>Checkpoint Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CKPT#NASDAQ">CKPT</a>) surged 28.6% to $3.42 after B. Riley Securities initiated coverage on the stock with a Buy rating and a $18 price target.</li>
	<li>Energous Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WATT#NASDAQ">WATT</a>) jumped 22.8% to $3.6617 after the company, and Atomosic Technologies, announced they have achieved the industry&#39;s first interoperability for radio frequency energy harvesting technology.</li>
	<li>Clean Energy Fuels Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNE#NASDAQ">CLNE</a>) jumped 20.5% to $11.94 after declining over 4% on Tuesday.</li>
	<li>American Software, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSWA#NASDAQ">AMSWA</a>) gained 18.7% to $24.13 after the company reported better-than-expected Q4 earnings.</li>
	<li>Root, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>) shares rose 18.4% to $13.38 after gaining around 15% on Tuesday. Root recently announced plans to enter into Wisconsin market.</li>
	<li>World Wrestling Entertainment, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WWE#NYSE">WWE</a>) surged 17.8% to $68.52.</li>
	<li>Orbital Energy Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OEG#NASDAQ">OEG</a>) jumped 17.2% to $5.72 after the company announced it was awarded a $64 million, 137-megawatt project from a Fortune 100 energy company.</li>
	<li>ZIOPHARM Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZIOP#NASDAQ">ZIOP</a>) gained 16.7% to $3.4199 on above-average volume.</li>
	<li>Inovio Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>) surged 16.4% to $9.99. Inovio Pharmaceuticals recently expanded its partnership with Advaccine Biopharmaceuticals Suzhou Co Ltd to jointly conduct a global Phase 3 part of the ongoing Phase 2/3 trial, INNOVATE, assessing its DNA COVID-19 vaccine candidate.</li>
	<li>Clovis Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLVS#NASDAQ">CLVS</a>) rose 15.2% to $6.58 after adding around 5% on Tuesday.</li>
	<li>NRx Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRXP#NASDAQ">NRXP</a>) gained 15.2% to $19.72.</li>
	<li>The9 Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCTY#NASDAQ">NCTY</a>) surged 14.5% to $14.98.</li>
	<li>Invesco Mortgage Capital Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVR#NYSE">IVR</a>) jumped 14.4% to $4.04.</li>
	<li>Global Ship Lease, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSL#NYSE">GSL</a>) surged 13.6% to $19.33 after the company announced an agreement to acquire 12 containerships for $233.9 million.</li>
	<li>CoreCivic, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CXW#NYSE">CXW</a>) gained 13.6% to $10.71 in sympathy with peer GEO Group, which has surged amid a short squeeze.</li>
	<li>Virios Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRI#NASDAQ">VIRI</a>) surged 12.6% to $6.33 as the company announced that data from its Phase 2a PRID-201 trial demonstrated that IMC-1 was better tolerated than placebo in patients with fibromyalgia.</li>
	<li>Ashford Hospitality Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHT#NYSE">AHT</a>) rose 11.8% to $7.00 after surging 20% on Tuesday.</li>
	<li>The9 Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCTY#NASDAQ">NCTY</a>) rose 11.8% to $14.62 after declining over 5% on Tuesday.</li>
	<li>Lyra Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYRA#NASDAQ">LYRA</a>) rose 11.6% to $8.78 after the company reported positive outcome of end-of-Phase 2 meeting with the FDA for LYR-210 for the treatment of chronic rhinosinusitis.</li>
	<li>Concord Medical Services Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>) gained 11.5% to $2.9979.</li>
	<li>SkyWater Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYT#NASDAQ">SKYT</a>) gained 9.6% to $29.21.</li>
	<li>Opera Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPRA#NASDAQ">OPRA</a>) rose 9% to $9.81 after falling over 23% on Tuesday.</li>
	<li>Clover Health Investments, Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLOV#NASDAQ">CLOV</a>) fell 8% to $20.36 after jumping over 85% on Tuesday.</li>
	<li>Ra Medical Systems, Inc.. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMED#NYSE">RMED</a>) shares rose 7.5% to $7.90 after dipping around 20% on Tuesday.</li>
	<li>F-star Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSTX#NASDAQ">FSTX</a>) gained 5% to $7.25 after B. Riley initiated coverage on the stock with a Buy rating and announced a $28 price target.</li>
</ul> 
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a><h3>Losers</h3><ul>
	<li>United Natural Foods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNFI#NYSE">UNFI</a>) shares dipped 19.7% to $32.61 after the company reported worse-than-expected Q3 sales and issued FY21 EPS guidance with a midpoint below consensus estimates.</li>
	<li>NextDecade Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXT#NASDAQ">NEXT</a>) fell 18.2% to $4.55. NextDecade shares climbed 60% on Tuesday after Evercore ISI upgraded the stock from In-Line to Outperform and raised its price target from $3 to $9.</li>
	<li>SemiLEDs Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEDS#NASDAQ">LEDS</a>) declined 15.7% to $21.77.</li>
	<li>Zhangmen Education Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZME#NYSE">ZME</a>) shares fell 14.5% to $14.52. The company&rsquo;s stock jumped over 47% on Tuesday after pricing its IPO at $11.50/ADS.</li>
	<li>Lordstown Motors Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIDE#NASDAQ">RIDE</a>) dipped 14.1% to $9.64 after the company&#39;s amended annual filing mentioned going concerns that current cash levels are not enough to begin commercial production.</li>
	<li>Atossa Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATOS#NASDAQ">ATOS</a>) fell 13.7% to $5.24 after the company disclosed the final data from its Phase 2 clinical study of oral Endoxifen administered in the &ldquo;window of opportunity&rdquo; between diagnosis of breast cancer and surgery.</li>
	<li>Comtech Telecommunications Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMTL#NASDAQ">CMTL</a>) dropped 12.8% to $22.38 after the company reported worse-than-expected Q3 sales results.</li>
	<li>Ondas Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONDS#NASDAQ">ONDS</a>) fell 12.5% to $7.83 after the company priced its underwritten public offering of 6,400,000 shares at $7.00 per share.</li>
	<li>AST SpaceMobile, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) dropped 11.3% to $10.77.</li>
	<li>Vera Bradley, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRA#NASDAQ">VRA</a>) fell 10.6% to $12.10 following Q1 results.</li>
	<li>CEL-SCI Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVM#NYSE">CVM</a>) fell 10.1% to $21.42 after the company announced a bought deal offering of $31.7 million via secondary equity offering.</li>
	<li>Precipio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPO#NASDAQ">PRPO</a>) fell 10.1% to $3.75. Precipio shares surged 18% on Tuesday after the company highlighted the launch of its HemeScreen Anemia Panel.</li>
	<li>Eastman Kodak Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KODK#NYSE">KODK</a>) dipped 9.6% to $9.97.</li>
	<li>Carver Bancorp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARV#NASDAQ">CARV</a>) fell 8.4% to $15.17. Carver Bancorp shares jumped over 15% on Tuesday amid a continued run up into Juneteenth, during which the stock saw a surge last year.</li>
	<li>Calavo Growers, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVGW#NASDAQ">CVGW</a>) dipped 7.6% to $67.76 following downbeat quarterly earnings.</li>
	<li>Campbell Soup Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPB#NYSE">CPB</a>) dropped 7.4% to $45.50 after the company posted downbeat Q3 earnings and lowered FY21 earnings forecast.</li>
	<li>GBS Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GBS#NASDAQ">GBS</a>) fell 7.3% to $3.1999.</li>
	<li>AMC Entertainment Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) fell 6.5% to $51.49.</li>
	<li>UiPath Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) fell 5% to $72.35 after the company reported a wider Q1 loss.</li>
</ul>

48 Stocks Moving In Wednesday's Mid-Day Session

<h3>Gainers</h3>

<ul>
	<li>Aethlon Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEMD#NASDAQ">AEMD</a>) shares surged 388.2% to close at $10.79 on Wednesday in reaction to Zacks Article &#39;AEMD: First Ever In Vivo Removal Of COVID Virus From Bloodstream Of An Infected Patient.&#39; The company recently announced the positive results from using its Hemopurifier in treating two critically ill COVID-19 patients, which is available under the FDA emergency use authorization (EUA).</li>
	<li>American Software, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSWA#NASDAQ">AMSWA</a>) jumped 39.1% to settle at $28.27 after the company reported better-than-expected Q4 earnings.</li>
	<li>The GEO Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) surged 38.4% to close at $8.80 amid continued retail investor interest in high-short interest stocks.</li>
	<li>Washington Prime Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WPG#NYSE">WPG</a>) gained 34.6% to settle at $6.73.</li>
	<li>Clean Energy Fuels Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNE#NASDAQ">CLNE</a>) surged 31.5% to close at $13.02 after declining over 4% on Tuesday.</li>
	<li>The9 Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCTY#NASDAQ">NCTY</a>) jumped 30.7% to close at $17.11.</li>
	<li>SPI Energy Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPI#NASDAQ">SPI</a>) gained 28.3% to settle at $7.99. SPI Energy&rsquo;s subsidiary Solar4America recently launched a new cloud-based online monitoring and maintenance system, Apollo, for solar systems, energy storage, and smart energy management.</li>
	<li>Takung Art Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TKAT#NASDAQ">TKAT</a>) surged 19.6% to close at $21.93.</li>
	<li>Atomera Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATOM#NASDAQ">ATOM</a>) jumped 19.3% to settle at $27.93 after Craig-Hallum initiated coverage on the stock with a Buy rating and announced a $28 price target.</li>
	<li>Checkpoint Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CKPT#NASDAQ">CKPT</a>) gained 19.2% to close at $3.17 after B. Riley Securities initiated coverage on the stock with a Buy rating and a $18 price target.</li>
	<li>Root, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>) shares gained 19.1% to close at $13.47 after gaining around 15% on Tuesday. Root recently announced plans to enter into Wisconsin market.</li>
	<li>Clear Channel Outdoor Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCO#NYSE">CCO</a>) surged 18.9% to settle at $2.83.</li>
	<li>Covanta Holding Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVA#NYSE">CVA</a>) jumped 18.7% to close at $17.64 on a report the company is exploring a sale.</li>
	<li>CoreCivic, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CXW#NYSE">CXW</a>) climbed 17.9% to settle at $11.12 in sympathy with peer GEO Group, which has surged amid a short squeeze.</li>
	<li>Lyra Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYRA#NASDAQ">LYRA</a>) jumped 17.9% to settle at $9.28 after the company reported positive outcome of end-of-Phase 2 meeting with the FDA for LYR-210 for the treatment of chronic rhinosinusitis.</li>
	<li>Invesco Mortgage Capital Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVR#NYSE">IVR</a>) surged 17.5% to settle at $4.16.</li>
	<li>Inovio Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>) climbed 16.8% to close at $10.03. Inovio Pharmaceuticals recently expanded its partnership with Advaccine Biopharmaceuticals Suzhou Co Ltd to jointly conduct a global Phase 3 part of the ongoing Phase 2/3 trial, INNOVATE, assessing its DNA COVID-19 vaccine candidate.</li>
	<li>DAVIDsTEA Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTEA#NASDAQ">DTEA</a>) jumped 16.4% to settle at $5.03.</li>
	<li>Triterras, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIT#NASDAQ">TRIT</a>) rose 16% to close at $7.40.</li>
	<li>Dolphin Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLPN#NASDAQ">DLPN</a>) surged 15.5% to settle at $10.43.</li>
	<li>Genetic Technologies Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GENE#NASDAQ">GENE</a>) gained 15.4% to close at $4.41. Infinity BiologiX, Genetic Technologies and Vault Heath launched a new Test to assess severity of COVID-19 in individuals.</li>
	<li>Cleveland-Cliffs Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) surged 14.6% to close at $23.22 as iron ore prices rose amid supply concerns. There is also growing interest in the stock within online trading communities.</li>
	<li>Antelope Enterprise Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHL#NASDAQ">AEHL</a>) shares gained 14% to settle at $4.55 on abnormally-high volume.</li>
	<li>Marqeta, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MQ#NASDAQ">MQ</a>) gained 13% to settle at $30.52 as the company priced its IPO at $27 per share.</li>
	<li>Connect Biopharma Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTB#NASDAQ">CNTB</a>) jumped 12.9% to close at $18.00.</li>
	<li>Energous Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WATT#NASDAQ">WATT</a>) gained 12.8% to close at $3.36 after the company, and Atomosic Technologies, announced they have achieved the industry&#39;s first interoperability for radio frequency energy harvesting technology.</li>
	<li>Opera Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPRA#NASDAQ">OPRA</a>) gained 12.6% to close at $10.13 after falling over 23% on Tuesday.</li>
	<li>ZIOPHARM Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZIOP#NASDAQ">ZIOP</a>) rose 11.6% to settle at $3.27 on above-average volume.</li>
	<li>World Wrestling Entertainment, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WWE#NYSE">WWE</a>) gained 10.9% to settle at $64.48.</li>
	<li>Global Ship Lease, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSL#NYSE">GSL</a>) gained 10.7% to close at $18.84 after the company announced an agreement to acquire 12 containerships for $233.9 million.</li>
	<li>Clovis Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLVS#NASDAQ">CLVS</a>) rose 10.5% to close at $6.31 after adding around 5% on Tuesday.</li>
	<li>Concord Medical Services Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>) surged 10% to close at $2.96.</li>
	<li>Virios Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRI#NASDAQ">VIRI</a>) gained 9.3% to close at $6.14 as the company announced that data from its Phase 2a PRID-201 trial demonstrated that IMC-1 was better tolerated than placebo in patients with fibromyalgia.</li>
	<li>SkyWater Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYT#NASDAQ">SKYT</a>) gained 7.2% to close at $28.56.</li>
	<li>Orbital Energy Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OEG#NASDAQ">OEG</a>) rose 7% to close at $5.22 after the company announced it was awarded a $64 million, 137-megawatt project from a Fortune 100 energy company.</li>
	<li>Ashford Hospitality Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHT#NYSE">AHT</a>) rose 6.4% to close at $6.67 after surging 20% on Tuesday.</li>
</ul>

&nbsp;

 
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>Atossa Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATOS#NASDAQ">ATOS</a>) shares tumbled 27.5% to close at $4.40 on Wednesday after the company disclosed the final data from its Phase 2 clinical study of oral Endoxifen administered in the &ldquo;window of opportunity&rdquo; between diagnosis of breast cancer and surgery.</li>
	<li>Clover Health Investments, Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLOV#NASDAQ">CLOV</a>) shares dipped 23.6% to close at $16.92 after jumping over 85% on Tuesday.</li>
	<li>SemiLEDs Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEDS#NASDAQ">LEDS</a>) dipped 21.8% to close at $20.20.</li>
	<li>NextDecade Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXT#NASDAQ">NEXT</a>) tumbled 21.4% to settle at $4.37. NextDecade shares climbed 60% on Tuesday after Evercore ISI upgraded the stock from In-Line to Outperform and raised its price target from $3 to $9.</li>
	<li>Clarivate Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLVT#NYSE">CLVT</a>) fell 19.6% to close at $26.39 after the company reported proposed offerings of $750 million ordinary shares and $1.25 billion convertible preferred shares.</li>
	<li>Carver Bancorp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARV#NASDAQ">CARV</a>) fell 16.5% to settle at $13.83. Carver Bancorp shares jumped over 15% on Tuesday amid a continued run up into Juneteenth, during which the stock saw a surge last year.</li>
	<li>United Natural Foods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNFI#NYSE">UNFI</a>) shares fell 15.7% to close at $34.26 after the company reported worse-than-expected Q3 sales and issued FY21 EPS guidance with a midpoint below consensus estimates.</li>
	<li>Dream Finders Homes, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DFH#NASDAQ">DFH</a>) dipped 14.8% to close at $26.93.</li>
	<li>Casper Sleep Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSPR#NYSE">CSPR</a>) slipped 14.7% to close at $10.10.</li>
	<li>Viant Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSP#NASDAQ">DSP</a>) fell 14.5% to settle at $29.06.</li>
	<li>Zhangmen Education Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZME#NYSE">ZME</a>) shares dropped 14.1% to close at $14.60. The company&rsquo;s stock jumped over 47% on Tuesday after pricing its IPO at $11.50/ADS.</li>
	<li>InnSuites Hospitality Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHT#NYSE">IHT</a>) dipped 13.9% to close at $9.94.</li>
	<li>Comtech Telecommunications Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMTL#NASDAQ">CMTL</a>) fell 13.8% to settle at $22.13 after the company reported worse-than-expected Q3 sales results.</li>
	<li>Asensus Surgical, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASXC#NYSE">ASXC</a>) tumbled 13.3% to close at $2.92.</li>
	<li>The Wendy&#39;s Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEN#NASDAQ">WEN</a>) fell 12.7% to settle at $25.21 ollowing its recent retail-driven surge. Stifel downgraded the stock from Buy to Hold and announced a $25 price target.</li>
	<li>AST SpaceMobile, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) dipped 12.5% to settle at $10.62.</li>
	<li>Eastman Kodak Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KODK#NYSE">KODK</a>) fell 11.6% to close at $9.77.</li>
	<li>GBS Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GBS#NASDAQ">GBS</a>) fell 11.6% to close at $3.05.</li>
	<li>CEL-SCI Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVM#NYSE">CVM</a>) fell 11.5% to settle at $21.08 after the company announced a bought deal offering of $31.7 million via secondary equity offering.</li>
	<li>AMC Entertainment Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) fell 10.4% to close at $49.34.</li>
	<li>UiPath Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) fell 9.6% to close at $68.71 after the company reported a wider Q1 loss.</li>
	<li>Precipio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPO#NASDAQ">PRPO</a>) fell 8.9% to close at $3.80. Precipio shares surged 18% on Tuesday after the company highlighted the launch of its HemeScreen Anemia Panel.</li>
	<li>Ondas Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONDS#NASDAQ">ONDS</a>) declined 7.3% to close at $8.30 after the company priced its underwritten public offering of 6,400,000 shares at $7.00 per share.</li>
	<li>Calavo Growers, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVGW#NASDAQ">CVGW</a>) dipped 7.1% to close at $68.14 following downbeat quarterly earnings.</li>
	<li>Vera Bradley, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRA#NASDAQ">VRA</a>) fell 6.9% to close at $12.61 following Q1 results.</li>
	<li>Campbell Soup Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPB#NYSE">CPB</a>) dropped 6.5% to close at $45.92after the company posted downbeat Q3 earnings and lowered FY21 earnings forecast.</li>
</ul>

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-08
REV		(EXPECTED)2021-08-08

Q1 2021		Est.		Actual		Surprise
EPS				-0.070
REV				48.101M

Recent Quotes

Earnings

Analyst Ratings

Related Companies

SkyWater Technology Frequently Asked Questions

How do I buy SkyWater Technology (SKYT) stock?

Who are SkyWater Technology's (SKYT) competitors?

What is the target price for SkyWater Technology (SKYT) stock?

Current Stock Price for SkyWater Technology (SKYT)?

Does SkyWater Technology (SKYT) pay a dividend?

When is SkyWater Technology (NASDAQ:SKYT) reporting earnings?

Is SkyWater Technology (SKYT) going to split?

What sector and industry does SkyWater Technology (SKYT) operate in?